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Cα,α-disubstituted amino acids (ααAAs) are widely utilized to conformationally 
constrain peptides. Several pentapeptides containing dipropylglycine (Dpg) at alternating 
positions and their α-amino acid counterpart L-norvaline (Nva) analogues were 
synthesized to fully investigate the impact of Dpg on peptide backbone structure in 
aqueous solution. CD, VCD and NMR spectral analysis suggest that Dpg containing 
peptides adopt more ordered structures relative to their Nva containing analogues. The 
central residues (Ala, Thr, Tyr, Val) and the charged side-chains of Glu and Lys play 
important roles in the degree of peptide folding. Hydrophobic and branched residues 
(Val, Tyr) at the central position of the peptide produce greater folding as judged by CD 
and NMR. Temperature-dependent NMR analysis (∆δ/∆Τ NH) of Ac-Glu-Dpg-Tyr-Dpg-
Lys-NH2 suggests a series of i→i+3 hydrogen bonds between the N-terminal acetyl 
carbonyl and the Tyr3 NH, and the Glu1 carbonyl and the Dpg4 NH. The solution 
conformation of Ac-Glu-Dpg-Tyr-Dpg-Lys-NH2 calculated from NMR-derived 
constraints shows a 310-helical structure (two repetitive type-III β-turns) at residues 1-4, 
which is supported by 2D NMR, CD and VCD spectra. Analysis of NMR-derived models 
of these peptides suggest that there is a strong hydrophobic interaction of the pro-S propyl 
side chain of Dpg2 and the Tyr3 side-chain that may be a strong stabilizing force of the 
peptide folding in water.   
Cα,α-diisobutylglycine(Dibg) was synthesized via palladium catalyzed allylation 
reaction with an excellent overall yield and incorporated into various positions of a model 
β-hairpin peptide GHP in order to determine the effectiveness of the ααAAs as design 
elements in both the strand and turn portions of β-hairpins. CD and NMR data of Dibg 
 xvi
containing peptides showed Dibg residue can contribute to the stability of the strand 
portion of a β-hairpin peptide and destabilize the β-turn in the GHP. The sheet stabilizing 
effect of Dibg may be due to the strong propensity of Dibg to have a fully extended 
conformation(φ/ψ= 180°). Several chiral amino esters were prepared with high 
enantioselectivity by alkylation of the corresponding Schiff bases under chiral phase-
transfer condition. The enantiomeric excess of these chiral amino esters was efficiently 
determined by 19F-NMR analysis of the corresponding diastereomeric Mosher amides. 
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CHAPTER 1: INTRODUCTION 
1.1 Protein Structure 
The 20 most common naturally occurring amino acids differ only in the side 
chains attached to the α-carbon. The difference of side chains is what is responsible for 
the structural variation and functional diversity of peptides or proteins. The three-
dimensional structure of a protein is crucial to its physical, chemical and biological 
properties. In nature, proteins adopt unique folded conformations that optimize their 
biological function. Thus, a good understanding of fundamental forces that determine 
peptide secondary structure will contribute our ability to design new peptides with 
specific structure and function. 
Protein structure has been classified into four different levels. Primary structure is 
the amino acid sequence in the protein chain. Secondary structure consists of a regularly 
repeating regional structure such as α-helix, β-sheet, turns, and random coil. Tertiary 
structure is the folding of secondary structure elements of a single peptide chain to give 
an overall fold or 3D structure. Quaternary structure is the spatial arrangement of the 
individual peptide chain resulting from the interactions between two or more individual 
polypeptide chains. Protein structures are stabilized by both covalent interactions which 
are responsible for the formation of amide bonds and three noncovalent interactions: 
electrostatic interactions, hydrogen bonds, and van der Waals interactions which are 
responsible for stabilization of the higher level of structures, such as secondary, tertiary 
or quaternary structures.  
The peptide bond possesses partial double-bond character which is depicted by a 
resonance structure (Figure 1.1) that leads to a planar and rigid amide group.  The 
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resonance form of the amide bond also demonstrates that the peptide bond itself is 
polarized such that the oxygen is a hydrogen bond acceptor and the N-H bond is a 
hydrogen bond donor. Hydrogen bonding interactions are a main force in stabilizing the 







Figure 1.1 Resonance structure of the amide bond 
Peptides form different secondary structures based upon the spatial arrangement 
of amide groups dictated by the backbone conformation. The conformation of a peptide 
backbone is characterized by a set of torsional angles φ and ψ with respect to the amide 
plane, in which φ is the rotation about the Cα-N bond and ψ is the rotation around the Cα-
CO bond(Figure 1.2). Different peptide conformations are associated with specific ranges 
of φ and ψ values. Table 1.1 lists the typical torsional angles associated with the various 















Figure 1.2 Torsional angles of the peptide backbone 
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Table 1.1 Torsional angles for helices and β-sheets a 
Conformation  φ  ψ Residues per turn/repeat 
α-Helix (right handed) -57° -47° 3.6 
α-Helix (left handed) 57° 47° 3.6 
310−Helix -60° -30° 3.0 
Parallel β-sheet -119° 113° 2.0 
Antiparallel β-sheet -139° 135° 2.0 
a Angles taken from IUPAC-IUB Commission on Biochemical Nomenclature (1970) 
 
Helices are one of the most common types of secondary structure in proteins in 
which amino acid residues are wrapped around a central axis to form an approximately 
cylindrical surface with intramolecuar hydrogen bonds parallel to the helix axis. The α-
helix has 3.6 residues per turn, stabilized by intramolecular hydrogen bonding between 
CO of residue i and the NH of residue i+4. The distance between adjacent amino acids is 
1.5 Å. The 310-helix contains 3 residues per turn, stabilized by intramolecuar hydrogen 
bonding between CO of residue i and the NH of residue i+3.  The distance between 
adjacent amino acids is 2.0 Å. The uniform alignments of amide groups with hydrogen 
bonded carbonyl groups in the helix generate helix dipole moment with a net positive 
charge at the N-terminus and a net negative charge at the C-terminus which is an 
important property for helical conformations. Baldwin et al. have shown that charged 
groups play a critical role in helix stability in aqueous solution by interaction with a 
nearby dipole of the helix.1 This interaction will stabilize helical structures if the two 
have opposite charge and will be helix-destabilizing when the two possess the same 
charge. This phenomenon has been noted as the charged group-helix dipole interaction. 
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The second main type of secondary structure is β-sheet, which form a sheet like 
structure in a zigzag format stabilized by intermolecular hydrogen bonding between two 
adjacent peptide strands, whereas in the helical structure the hydrogen bondings are 
between NH and CO in the same strand. The distance between adjacent amino acids is 
3.5 Å. Two types of β-sheets exist, parallel β-sheet and antiparallel β-sheet, having 
polypeptide strands either parallel or antiparallel to each other. 
The third main type of secondary structure in protein is turns. β-Turn and γ-turn 
contain consecutive four and three amino acid residues respectively, where the 
polypeptide chain folds back on itself by nearly 180 degrees. β-Turns are stabilized by a 
hydrogen bond between the carbonyl of the residue i and the NH of the residue i + 3 as 
shown in Figure 1.3. While γ-turns are stabilized by a hydrogen bond between the 
carbonyl of the residue i and the NH of the residue i + 2. It is these chain reversals which 
give a protein its globularity rather than linearity.  Lewis et al. found that 25% of β-turns 
do not possess the hydrogen bond.2 Therefore the broadened definition of β-turns is that 
the distance between the alpha carbon of residue i and the alpha carbon of residue i+3 
should be less than 7 Å. It should be noted that the type-III β-turn possesses the same 
torsional angles as a 310 helix structure. Thus, the type-III β-turn is equivalent to a 310 















Figure 1.3 β-Turn structure, hydrogen bonds are indicated by dotted lines 
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Table 1.2 Typical torsional angles for various β-turnsa 




φi+1 φi+2 ψi+1 ψi+2 3 
Type-I -60 -90 -30 0 3 
Type-I' +60 +90 +30 0 3 
Type-II -60 +80 +120 0 3 
Type-II' +60 -80   -120 0 3 
       Type-III     -60   -60   -30 -30 3 
a For β-turn, the torsional angles from two consecutive amino acid residues i+1 and i+2 in 
the middle of the turn are used to define the structure.  
b Torsional angels taken from Ref 3.3 
 
1.2 Commonly Used Techniques for Conformational Analysis of Peptides 
The three-dimensional structure of peptides can provide valuable information on 
their properties and biological functions. Circular dichroism (CD), fourier transform 
infrared (FTIR), and nuclear magnetic resonance (NMR) analysis are commonly used 
spectroscopic techniques to interpret peptide structures in solution.  
• Circular Dichroism (CD) Study of Peptide Conformation  
Circular dichroism (CD) spectroscopy has been widely used to probe peptide 
secondary structure in solution. Circular dichroism spectroscopy measures the difference 
between the absorption of left- and right-handed circularly polarized light by a chiral 
molecule.4 The interaction between transition moments leads to CD and the geometrical 
relation between amide groups in different secondary structures leads to the characteristic 
CD spectra of different secondary structures. There are two types of CD spectroscopies: 
circular dichroism due to electronic transitions is referred to as CD(also as ECD) and that 
due to vibrational transitions as VCD. Most CD measurements are reported in molar 
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ellipticity as:  [θ] = 100 θ / C*l in the unit of deg cm2dmol-1 where C and l are the molar 
concentration of the sample and pathlength in cm, respectively. 
CD spectra of peptides in the far-UV (190-250 nm) region are dominated by the 
amide chromophores and reflect primarily the conformation of the peptide backbone, 
which is diagnostic for the peptide secondary structure. CD spectra of peptides in the 
near-UV (250-300 nm) region are the contributions of aromatic and sulfur-containing 
side chains. Some CD spectra show a positive interfering band around 224 nm for the 
aromatic side chains and a negative band around 228 nm for sulfur-containing side chains. 
In most cases, a CD spectrum below 260 nm is governed by the amide chromophore, and 
the side-chain contribution is negligible.5 
α-Helices are characterized by double minima at 210 nm (π-π* transitions) and 222 
nm (n-π* transitions); β-sheets show a single, broad, negative band at 212 nm (n-π* 
transitions) and a positive band near 195 nm; random coils exhibit a strong, negative 
band at 195 nm. A typical β-turn CD spectrum exhibits a negative band near 225 nm(n-
π* transitions), a strong positive π-π* transition between 200 nm and 205 nm.6 CD is a 
quick method that requires only small amount of peptide, and thus can be used to survey 
the effects of differing pH, temperature and solvent conditions on peptide conformations. 
CD experiments are carried out in solution phase that is important for the study of 
biological systems because it can provide the structure in a near physiological condition. 
CD is dependent upon a cooperative effect of the amide transitions and thus is 
positionally averaged and doesn’t give site-specific information. 
• Fourier Transform Infrared (FTIR) 
     Amide I and amide II regions in FTIR are often utilized to extract secondary structural 
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information of peptides from amide stretching bands.7  Amide I band results from 
stretching vibrations of the backbone carbonyl groups and amide II band results from the 
N-H bending vibration. The frequency of the vibration is determined by the nature of the 
hydrogen bonding and backbone conformations. α-Helices show the amide I band at 
about 1655 cm-1 and the amide II band at 1540 cm-1; β-sheets exhibit the amide I band at 
1630 cm-1 and the amide II band at 1520 cm-1 ; random coils show the amide I and II at 
1660 and 1535 cm-1 respectively. FTIR spectroscopy in some cases can give information 
on the relative populations of various folded conformations in solution.   
• NMR Analysis of Peptide Secondary Structure 
The determination of peptide structures by nuclear magnetic resonance (NMR) 
has come into wide use in the last twenty years. The technique uses peptide samples in 
aqueous solution, rather than crystals. Thus it can provide the structure close to 
physiological conditions.  Parameters such as nuclear overhauser effect (NOE), rotating 
frame overhauser enhancement (ROE), chemical shift deviation from the random coil 
conformation, temperature coefficients of amide protons, and coupling constant have 
been routinely used in the elucidation of peptide structures by NMR. 
 NOE and ROE can detect distances of pairs of protons less than 5 Å. The 
interproton distances serve as NMR restraints and are used to construct a three-
dimensional structure of a peptide through molecular dynamics and energy minimization 
methods. The NOE connectivities can also provide information on the types of 
conformations present in solution because different peptide conformations are associated 
with specific NOE connectivity patterns. Sequential dNN(i,i+1) NOE connectivities, 
medium-range NOE connectivities dαN(i,i+2), and dαN(i,i+3) are observed, if the peptide 
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has a significant population of turns or helices, whereas long range NOE connectivities 
and strong sequential dαN(i,i+1) NOE connectivities with the absence of dNN(i,i+1) NOEs 
are observed if the peptide adopts an extended conformation.8 
α-Proton chemical shifts have been proven to be highly sensitive to peptide 
backbone conformation. They experience upfield shifts relative to the random coil 
structure when in a helical or turn structure and exhibit downfield shifts from the random 
coil value when in a β-sheet structure.9 Carbon chemical shifts of α-carbons and carbonyl 
carbons are also conformationally dependent, with residues in helical structures showing 
downfield shifts and with residues in β-sheet structures showing upfield shifts relative to 
the random coil values.  
 Wishart and coworkers have demonstrated that “chemical shift index” (∆δHα = 
δHα(observed) - δHα(random coil)) provides qualitative insight on secondary structure. A group of 
three or more residues with ∆δHα >0.1 ppm are considered to be β-strands. A group of 
residues containing four or more residues with ∆δHα <0.1 indicate helical or turn 
structures.9 Gellman et al. and Searle et al. have reported that α-proton resonances are 
reliable reporters for the quantitative analysis of β-hairpin populations.10-12 The β-hairpin 
populations can be quantitatively determined in aqueous solution by comparison of the 
chemical shifts of α-proton in the sheet portion or the diastereotopic glycine α-protons of 
the peptide of interest relative to those of reference compound representing the unfolded 
and fully folded states by using the following equations: 
f = (δobserved –δunfolded)/(δfully folded-δunfolded)  
f = ∆δGlyobserved /∆δfully folded 
where f = mole fraction of hairpin folded and δobserved is the chemical shift of α-hydrogens 
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of the sheet portion  or glycine α-protons observed experimentally, δunfolded is the 
chemical shift of the α-proton in the fully unfolded state, and δfully folded is the chemical 
shift of the α-proton in the fully folded state. The extent of folding can be related to the 
equilibrium constant K, by the following equation, K = f/(1-f).  The free energy change 
can then be determined from ∆G = -RT ln K.   
The chemical shift of the amide proton resonance depends upon the temperature; 
the temperature dependences of amide proton chemical shifts (temperature coefficients) 
are frequently measured to locate intramolecular hydrogen-bonds.13 Hydrogen-bonded 
(exchange-protected) amide protons typically display reduced temperature coefficients 
with respect to non-hydrogen bonded, solvent exposed amide protons. 
Coupling constants 3JHNHα are dependent on the angle between amide proton and 
α-proton and can be converted to the dihedral angle φ based on Karplus equation:14 
3JHNHα = 6.51cos2 (φ−60°)−1.76cos (φ−60°)+1.60.   The calculated φ with a +/-10° limit 
are often introduced as torsion angle restraints for structural calculation.   
COSY enables one to see correlations between coupled protons. TOCSY 
correlates all protons within the same spin system. ROESY correlates protons that are 
close to each other in space, typically 4.5 Å or less. HSQC correlates protons with their 
directly attached carbon nuclei. HMBC detects long range coupling between proton and 
carbon on these two and three bond couplings. HSQC-TOCSY spectrum correlates one-
bond 1H-13C couplings and shows these correlations throughout an entire spin system.15 
1.3  Fmoc Solid Phase Peptide Synthesis 
Solid phase peptide synthesis (SPPS) introduced by Robert Bruce Merrifield in 
1963 has been significantly advanced over the past five decades and has greatly 
 10
facilitated the synthesis of peptides and small proteins.16 Dr. Merrifield was awarded the 
1984 Nobel Chemistry Prize for the invention of SPPS. The basic principle of SPPS is the 
construction of a peptide chain on an insoluble polymeric support via stepwise coupling 
of suitably protected amino acids to the solid support. The polypeptide chain is then 
extended one amino acid at a time from the C to N-terminus. Since the insolubility of 
polymers allows purification simply by wash and filtration, it can save an enormous 
amount time and effort on peptide synthesis and purification. It also produces high yield, 
high purity peptides in comparison with solution phase peptide synthesis. Fmoc SPPS 
introduced in 1970s has made the SPPS safer to carry out relative to the original Boc 
form SPPS by avoiding the use of hydrofluoric acid. Fmoc SPPS is now the most 
commonly used technique for peptide synthesis in research laboratories.  The principles 
of Fmoc solid phase synthesis are illustrated in Figure 1.4.  
• Protecting groups used in Fmoc SPPS 
In Fmoc SPPS, excess amino acids and activating reagents are used to drive each 
coupling reaction to completion. Reactive functional side chain groups and the amino 
group of amino acids need to be protected in order to prevent the formation of undesired 
side products. Fmoc group is used for temporary protection of α-amino group and is 
removed before each coupling by piperidine to form dibenzofulvene via a β-elimination 
mechanism as shown in Figure 1.5.  The dibenzofulvene is then scavenged by piperidine 
to afford the piperidine-dibenzofulvene adduct which is UV visible and is used to 
monitor the progress of coupling reactions in the Fmoc solid phase peptide synthesis 
quantitatively.  Acid labile side chain protecting group, such as Pbf, Boc, t-butyl, and 
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trityl, are removed using TFA at the same time as cleavage of the peptide off the resin as 


































































P = Side-chain protecting group
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Side-chain protecting groups are stable to piperidine treatment
but are cleaved by trifluoracetic acid (TFA) as denoted by
 
Figure 1.6 The commonly used protecting groups for the Fmoc SPPS 
• Peptide Coupling Reagents 
The effective acylation of amino group to form the amide bond requires carboxyl 
group of incoming amino acids to be activated. Traditionally, this activating step is 
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carried out with dicyclohexylcarbodiimide (DCC) which activates the carboxyl group by 
the formation of a highly reactive species O-acylisourea which can lead to racemization 
and undergo a rearrangement to give unreactive species. Thus, 1-hydroxy-benzotrizaole, 
(HOBt)17 or 1-hydroxy-7-azabenzotriazole (HOAt)18 has been used as an additive to 
capture active species and  give the corresponding esters which are less reactive and less 
tend to racemization. 18 In the last decade, coupling reagents uronium and phosphonium 
salts based on hydroxybenzotriazole derivatives such as HATU, HBTU, TBTU, PyAOP 
and PyBOP have been widely used for in situ carboxyl activation as shown in Figure 
1.7.19,20 These reagents activate the carboxyl group by converting Fmoc-amino acids in 
the presence of a tertiary base such as DIEA to their corresponding active OAt or OBt 


















































PyAOP PyBOP  
Figure 1.7 Uronium and phosphonium activating reagents  
PyAOP is more reactive than PyBOP, and used to effectively incorporate 
sterically hindered amino acids such as Aib and Dpg into the peptide sequence. PyAOP 
and PyBOP are preferred to their uronium counterparts such as HATU and HBTU 
 14
because uronium can block amino terminus for further peptide chain assembly through 
formation of a tetramethyl-guanidinated residue at amino terminus.21 Symmetrical 
anhydrides, the pre-formed activated amino acid derivatives are ideal reagents for 
incorporation of hindered amino acids. These symmetrical anhydrides can be prepared by 
reaction of 2 equivalents of Fmoc-amino acids with 1 equivalent DCC in CH2Cl2.  
1.4  Design of Synthetic Peptides Containing ααAAs as Inhibitors for Protein    
Conformational Diseases 
 
Cα,α−disubstituted amino acids (ααAAs) have been widely recognized as a means 
of introducing backbone conformational constraints in peptides and used as 
stereochemical directors of polypeptide chain folding.22 Conformationally constrained 
peptides often have improved activity, bio-stability, and bioavailability.23, 24  Peptide-
based and peptide mimetic-based drugs provide significant medical relief and 
chemotherapy for a number of ailments including AIDS,25 and prostate cancer.26 
Protein or polypeptides conformational misfoldings from normal protein geometries 
to β-sheet conformation are thought to be key pathogenic factors  in several protein 
conformational diseases, including Alzheimer’s disease (AD), diabetes type II, Parkinson 
diseases and prion disorders,27-31 in which the misfolded protein self-aggregates to 
amyloid fibrils and deposits as amyloid plaques in diverse organs promoting tissue 
damage and organ dysfunction. The interruption of the formation of the β-sheet 
conformation of the amyloid peptide by ααAA-containing peptides has been shown to be 
a promising therapeutic approach to development of the fibrilization inhibitory drug.  
Our group has recently developed a novel ααAA-containing peptide-based approach 
for disrupting  the hydrogen bonding network in amyloid-β peptide (Aβ) and  inhibiting 
the formations of  fibril or protofibril,32 which leads the formation of amyloid plaques, 
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the proposed causative agent leading to the progression of Alzheimer’s disease and brain 
cell death. The ααAAs with side chain larger than ethyl have been shown to stabilize 
extended peptide conformations. The hypothesis of the Hammer group design of 
inhibitors of Aβ fibril formation is that peptides containing steric hindered 
α,α−disubstituted amino acids (ααAAs) in the hydrophobic core of Aβ  can interact with 
Aβ by hydrogen bonding as well as by side-chain interactions, but hydrogen bonding was 
blocked on the opposite edge. Thus, further aggregation of Aβ into toxic protofibril or 
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Edge of sheet blocked due to the presence of α,α-disubstituted amino acides  
Figure 1.8 Design of peptides with ααAAs as blockers of Aβ assembly 
Conformational preferences of Aib have been characterized in a variety of 
peptides. The presence of two sterically bulky methyl groups on the α-carbon greatly 
restricts the rotational freedom of the backbone torsional angles φ and ψ and strongly 
favors helical conformations. The very high tendency of Aib to induce helical 
conformations has been used to design of helical inhibitors to disrupt the formation of β-
sheet structure. Formaggio et al. have demonstrated that a single amino acid replacement 
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of Val at position 2 with Aib in the protected pentapeptide benzyloxycarbony-Leu-Val-
Phe-Phe-Asp(OtBu)-OtBu, which corresponds residue 17 to residue 21 of the amyloid-β 
peptide, induces helical structure and completely disrupt the β-sheet structure of this 
amyloid-β peptide fragment in organic solvent.33 
Aib has also proven to be a good β-sheet breaker amino acid; it disrupts β-sheet 
structure in a variety of peptides.22, 34 Therefore, Aib has been used as β-breaker element 
for the design of peptide-based inhibitor for amyloid fibril formation in protein 
conformational diseases. Gazit et al. have elegantly designed an Aib-containing peptide 
to inhibit human islet peptide hIAPP amyloid fibrillization by preventing the β-sheet 
formation.35  hIAPP, a 37 amino acid hormone peptide, accumulates as islet amyloid 
fibrils and deposits in the pancreas of type II diabetes patients. The inhibitor peptide was 
based on the amino acid sequence, Ala-Asn-Phe-Leu-Val-His, which corresponds to 
residue 13 to residue 18 of the hydrophobic core of hIAPP peptide. Fibrillization can be 
inhibited by replacing alanine (residue 13) and leucine (residue 16) with Aib. This 
designed inhibitor has shown a high affinity for the hIAPP molecule and exhibits 
significant inhibition toward fibril formation of hIAPP peptide determined by electron 
microscopy (EM), Congo red (CR) birefringence, and FTIR spectroscopy assays.  
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SHORT FOLDED PEPTIDES IN AQUEOUS SOLUTION:  ROLE OF α,α-
DISUBSTITUTED AMINO ACID AND CENTRAL RESIDUES ON 
PENTAPEPTIDE STRUCTURES                                                                         
2.1 Introduction  
Design, synthesis, and conformational analysis of short peptides that fold into 
defined structures have greatly improved our understanding of protein folding1-4 and 
stability, and have produced a number of breakthroughs in biologically active materials 
with enhanced potential to fight diseases.5, 6 Cα,α−disubstituted amino acids (ααAAs) are 
widely utilized to conformationally constrain peptides and to stabilize particular secondary 
structures. Short peptide sequences, which generally would not be structured, can be 
induced to fold by the introduction of ααAAs into the sequence. ααAAs affect this folding 
by acting as stereochemical directors of polypeptide backbone conformation, through the 
phenomenon commonly referred to as the Thorpe-Ingold effect, or the gem dialkyl effect.7  
A large body of research shows that Aib (α-aminoisobutyric acid or α,α-
dimethylglycine) favors helical conformations in a wide variety of peptides of differing 
lengths and sequences.8, 9 The presence of two methyl groups on the α-carbon restricts the 
rotational freedom of the backbone torsional angles φ and ψ,  and tends to constrain the 
backbone torsional angles to favor formation of 310 (φ = ±57°, ψ = ±30°) and α (φ = ±63°,  
 ψ = ±42°) helices. The high helical propensity of Aib has been utilized by nature to make 
helical antimicrobial peptides.10 Additionally Aib has been utilized in de novo design 
helical peptides with antimicrobial activity and design helical inhibitors against HIV-1 
virus entry into cells.6 Aib has also proven to be a good β-sheet breaker amino acid, 
therefore it is used as a beta-breaker element for the inhibition of amyloid fibril formation 
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by human islet amyloid polypeptide (hIAPP), which is associated with the pathogenesis of  
type II diabetes.11  
Less is known about the conformation of peptides containing ααAAs with side-
chains larger than methyl group, such as Deg (diethylglycine), Dpg (di–n-propylglycine), 
and Dbg (di-n-butylglycine). These amino acids are unique in that they have been shown 
to adopt both extended and helical conformations, depending on their sequence context, 
length, and environmental factors.12-30 In the case of Aib, conformational energy 
calculations suggest that helical conformations are significantly more stable than fully 
extended conformations. In contrast, the higher dialkylglycines have similar energy 
minima in both the fully extended (φ, ψ∼ ±180ο ) and helical conformations.7 The 
coexistence of a fully extended conformation and a helical conformation in single crystals 
of the peptide Boc-Leu-Dpg-Val-OMe agrees well with those theoretical calculations.30 
There are no studies to date that fully explain the context-dependent conformational 
preference of these ααAAs and their influence on neighboring residues. Previous studies 
relied heavily on solid-state structures of peptides crystallized from organic solvents, 
which may deviate from solution conformations of ααAA-containing peptides in aqueous 
(physiologically relevant) medium.31  
In short water-soluble peptides, the water molecules compete very effectively 
with the intramolecular hydrogen-bonding between the carbonyl and amide groups of 
peptide backbone. Early calculation and experimental results suggest that short linear 
peptides would not adopt ordered structures in water; as a result, the general belief for 
many years was that short water-soluble peptides adopt random coil conformations in 
water. With the improvements for the experimental techniques, Dyson et al. demonstrated 
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that small peptides with four to six residues adopt β-turn conformations in water.32 In 
correlation with statistical studies on β-turn probability performed by Chou and Fasman, 
Dyson et al. also demonstrated that β-turn conformational propensity is dependent on the 
local amino acid sequence, rather than on medium- to long-range interactions. Toniolo et 
al. reported the first two water soluble  310-helical peptides, which contain  five residues 
of highly helical inducing α,α-disubstituted amino acids, either α-aminoisobutyric 
acids(Aib) or isovalines(Iva) with two water-solubilizing, azacrown-functionalized α-
amino acids, L-2-amino-3[1-(1,4,7-triazacyclononyl)]propanoic acid(ATANP).33, 34 The 
310-helical conformation of the heptapeptides was mainly attributed to high Aib and Iva 
content and main chain length favoring helical conformation.  
The conformational analyses of Dpg containing peptides have only been 
conducted in organic solvents and solid states. It is necessary to fully investigate the 
impact of Dpg on peptide backbone structure in biocompatible aqueous solution. For this 
reason, several pentapeptides containing Dpg and its α-amino acid counterpart L-
norvaline (Nva) at alternating positions (Table 2.1) were synthesized using solid phase 
Fmoc chemistry and their conformational preferences were analyzed in aqueous 
phosphate buffer. Glutamic acid and lysine residues were incorporated at each end of the 
peptide sequence to probe the potential conformational effects resulting from charge-
charge, or charge-dipole interactions. Residues with different conformation preferences 
such as alanine, threonine, tyrosine, and valine were incorporated at the central position 
(residue 3) of the peptides to examine the sequence effect in stabilizing extended or 
helical conformations. Charge-dipole interactions were analyzed by switching the order 
of glutamic acid and lysine. The conformation of these peptides was initially probed by 
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CD.  Several of the more structured peptides were further investigated by multi-
dimensional NMR techniques which indicated that several of the Dpg-containing 
peptides were likely helical in structure. Conformations of the peptide containing Tyr at 
the central residue, Ac-Glu-Dpg-Tyr-Dpg-Lys-NH2 constructed via 1H NMR-based 
structure calculations show that this peptide has a type-III turn or 310 helix geometry.   
2.2       Results and Discussion 
2.2.1     Peptide Synthesis 















                                    a EK-Dpg-T and EK-Nva-T were synthesized by Yanwen Fu. 
  Peptides were synthesized using standard solid-phase Fmoc chemistry on Fmoc- 














PAL-PEG-PS resin. The primary sequences of Dpg and Nva containing peptides are 
listed in Table 2.1. Our group has previously found that coupling Dpg to the peptide 
sequence could be greatly improved at elevated temperatures, thus the coupling of Dpg 
containing peptides were carried out at 50 ºC using PyAOP activation. For these difficult 
couplings, we prefer the phosphonium-based coupling reagent over uronium reagents like 
HATU and HBTU as it avoids chain termination via guanidinium form at amino 
terminus.35 A particular difficult peptide to synthesize is EK-Dpg-V due to the steric 
hindrance between Val and Dpg residues. Double coupling of Val3 to Dpg4 and Dpg2 to 
Val3 is necessary to avoid the deletion sequence. After the last amino acid coupling, 
acetylation of the N-terminus of all peptides was carried out manually with acetic 
anhydride in DMF. 
2.2.2 Conformational Analysis by Circular Dichroism (CD) 
Minimum and maximum ellipticities and corresponding wavelength of CD spectra for 
Dpg and Nva peptides are listed in Table 2.2. 
Variation of the sequence, as detailed in Table 2.1, incorporation of glutamic acid or 
lysine residues at residue 1 and residue 5 of EE-Dpg-Y, EK-Dpg-Y, KK-Dpg-Y, and KE-
Dpg-Y was designed to evaluate the potential conformational effects resulting from 
residue-residue charged side chain interactions or charge-dipole interactions. The EE-
Dpg-Y, KK-Dpg-Y, KE-Dpg-Y exhibit similar CD spectra at pH 7.0 with a negative 
band at about 190 nm, a positive band near 200 nm, and a weak negative band at 230 nm 
as shown in Figure 2.1. The CD spectrum of EK-Dpg-Y has the same sign pattern, but is 
much more intense so that its positive band at 200 nm and negative band at 230 nm gives  
it characteristics that have been previously attributed to a β-turn conformation,36  but may  
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but may also arise from the aromatic group of Tyr. The intensity difference may be due to 
side chain interactions between negatively charged Glu side chain(Glu-) or positively 
charged Lys side chain(Lys+) or interactions between charged side chains and a helix 
dipole in EK-Dpg-Y. Reversal of Glu and Lys residues in KE-Dpg-Y reduces the 
structure of the peptide, which may be due to interactions of the Glu and Lys with a helix 
dipole in EK-Dpg-Y that  stabilizes a turn structure.37, 38  The helix dipole moment is an 
important property of helices that is generated by the uniform alignments of hydrogen 
bonds in the helix. Baldwin and coworkers have shown that charged groups play a critical 
role in stabilizing helices in aqueous solution.37 Helical structures are stabilized if the 
side-chain group and pole of the helix have opposite charges, e.g.  Glu- on the N-terminus 





























Figure 2.1 CD spectra of 100 µM peptide concentration of EE-Dpg-Y, EK-Dpg-Y, KK-   
Dpg-Y, and KE-Dpg-Y in 10 mM phosphate buffer, pH 7.0, recorded at 20°C. 
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Table 2.2 Minimum and maximum ellipticities and corresponding wavelength of CD          
spectra for Dpg and Nva containing peptides                 
Peptide Name      Min/Max 
λ (nm)          θx(103) 
Min/Max 





5.82 232 -6.53 
EK-Dpg-Y 200 40.8 231 -21.6 
KK-Dpg-Y 200 5.35 230 -3.70 
KE-Dpg-Y 201 0.36 232 -2.69 
EK-Dpg-T 192 -5.30 226 -2.01 
EK-Dpg-A 194 -20.0 229 -5.28 
EK-Dpg-V 201 -20.3 226 -12.9 
EK-Aib-Y 200 2.48 230 -5.65 
EK-Nva-Y 195 -7.52 223 -1.03 
EK-Nva-T 197 -13.7 226 -1.38 
EK-Nva-A 198 -36.6 227 
 
-5.15 










To further test the hypothesis that EK-Dpg-Y is stabilized by the interactions of 
Glu- and Lys+ with a helix dipole in EK-Dpg-Y, CD measurements of EK-Dpg-Y were 
carried out in phosphate buffer solutions at differing pH values as shown in Figure 2.2.  
 



























Figure 2.2 pH dependent CD spectra of 100 µM peptide concentration of EK-Dpg-Y in 
10 mM phosphate buffer at differing pH, recorded at 20 °C. 
 
A systematic reduction of molar ellipticity values at 200 nm and less negative 
bands at 230 nm were observed when the pH value was decreased. This phenomenon 
indicates a reduction of ordered structures at lower pH presumably due to the conversion 
of Glu- to Glu0 and the loss of the favorable interaction between side-chain of Glu and the 
helix dipole in this peptide.  
Conformational preferences of Aib have been characterized in a variety of 
peptides. It is well established that Aib, is a strong promoter of alpha and 310 helical 
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conformations. EK-Aib-Y was synthesized in which Dpg residues were replaced by Aib 
to investigate if Aib and Dpg possess the similar structural effects on the peptide 





























Figure 2.3 CD spectra of 100 µM peptide concentration of EE-Dpg-Y, EK-Dpg-Y, KK-  
Dpg-Y, KE-Dpg-Y, and EK-Aib-Y in 10 mM phosphate buffer, pH 7.0, recorded at 20°C. 
 
The CD spectrum of EK-Aib-Y displays a diminishing positive band at 200 nm and a 
weaker negative band at 230 nm compared to EK-Dpg-Y, EE-Dpg-Y, and KK-Dpg-Y, 
suggesting that Aib destabilizes the structure as shown in Figure 2.3. 
To further investigate the ααAA impacts on the peptide backbone conformation, 
L-norvaline (Nva) analogs were prepared. The CD spectrum of EK-Nva-Y has no near-
UV structure and only a negative minimum at 195 nm indicative of a random coil 
structure as illustrated in Figure 2.4. 
The CD spectra of the EK-Dpg-T, EK-Nva-T, EK-Dpg-A, and EK-Nva-A are 
dominated by negative bands at ~197 nm indicative of mostly random coil structures as 
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shown in Figure 2.5. The negative band near 197 nm is stronger for EK-Nva-T than for 
EK-Dpg-T and the same is true for EK-Nva-A as compared to EK-Dpg-A, suggesting 
that Dpg residues impose backbone constraints in comparison with Nva containing 
peptides. These results also suggest that the hydrophobic central residue may play an 
important role in these peptide structures since with the central Tyr residue the CD has a 
distinctly different shape. 
The CD spectrum of EK-Dpg-V shows two minima at 202 nm and 227 nm which 
suggests that EK-Dpg-V adopts a different, possibly turn-like structure. The CD spectrum 
of EK-Nva-V has a negative band at 197 nm consistent with a coil-like structure as 
illustrated in Figure 2.6. 

























Figure 2.4 CD spectra of 100 µM peptide concentration of EK-Dpg-Y and EK-Nva-Y, in 




Figure 2.5 CD spectra of 100 µM peptide concentration of EK-Dpg-T, EK-Nva-T, EK-




Figure 2.6 CD spectra of 100 µM peptide concentration of EK-Dpg-V and EK-Nva-V in 

























The concentration dependence studies for both EK-Dpg-Y and KE-Dpg-Y were 
carried out at peptide concentrations of 100, 250, 500 µM in phosphate buffer at pH 7, 
The CD spectra are concentration independent for both peptides, indicating stable 
secondary structures and no aggregation in the two peptides. The temperature dependence 
study of EK-Dpg-Y shows unchanged CD bands under measured temperature indicting a 
stable secondary structure is preserved over temperatures. The temperature dependence 
study of KE-Dpg-Y shows decreasing of the maximum at 200 nm over the temperature, 
indicating instability of this peptide at higher temperature. 


























Figure 2.7  The concentration dependent study of the CD spectra of KE-Dpg-Y in 10 
mM of phosphate buffer, 20 ºC. 
 
The concentration dependence study for EK-Aib-Y was carried out at peptide 
concentrations of 100 µM, 250 µM and 500 µM in phosphate buffer at pH 7. A red shift 
occurs form 200 nm to 202 nm as increasing the concentration, indicating the secondary 
structure is not stable as shown in Figure 2.8. 
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Figure 2.8 The concentration dependent study of the CD spectra of EK-Aib-Y in 10 mM 
of phosphate buffer, 20 ºC. 
 
CD spectra of peptides in the near-UV (250-300 nm) region are the contributions 
of aromatic and sulfur-containing side chains. Some CD spectra show a positive 
interfering band around 224 nm for the aromatic side chain and a negative band around 
228 nm for sulfur-containing side chains.39 In most cases, a CD spectrum below 260 nm 
is governed by the amide chromophore, and the side-chain contribution is negligible. 
2.2.3     Conformational Analysis by IR and VCDa 
By comparison, the IR and VCD spectra for the EK-Dpg-Y, KE-Dpg-Y, EK-Dpg-
V, and EK-Aib-Y peptides are quite similar as shown in Figure 2.9 and Figure 2.10 
repectively.  The amide I absorbance peaks at ~1637 cm-1 in both the FTIR and the VCD 
is quite weak for both but has a positive couplet shape, which would be consistent with a 
partial, local 310 helical conformation. These data are inconsistent with a disordered form 
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for either and with a large difference in their structures.  The side-chains, particularly Tyr 
do not interfere with IR or VCD measurements. 



















Figure 2.9 Amide I′  absorbance (1637 cm-1) and tyrosine band (1516 cm-1)  FTIR 
spectra for  40 mM of EK-Dpg-Y, KE-Dpg-Y, EK-Dpg-V, and EK-Aib-Y. Each band 
was normalized to a maximum of 1.0 for comparison. 
 


















Figure 2.10 VCD spectra of 40 mM of EK-Dpg-Y, KE-Dpg-Y, EK-Dpg-V, and  
                     EK-Aib-Y 
 
a IR and VCD were run by Ling Wu at University of Illinois at Chicago. 
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2.2.4  1H and 13C NMR Resonance Assignments 
The ultimate goal of the NMR experiment is to obtain proton-proton distances 
(from ROESY) and other restraints(e.g. 3JHNHα ) to be used in 3D structure calculations. 
As a precursor to this thought protons much first be assigned. 
1H and 13C NMR resonance assignments of EK-Dpg-Y were obtained using the 
combination of DQF-COSY, TOCSY, ROESY, HSQC, HSQC-TOCSY, and HMBC 
spectra. The first step in the 1H NMR resonance assignment of EK-Dpg-Y is the 
identification of the 1H spin systems of the individual amino acid residues for Glu1, Tyr3, 
and Lys5 via through-bond 1H-1H connectivities using COSY and TOCSY spectra. 
(Figure 2.12 and blue arrows in Figure 2.11) The different spin systems of the 20 
proteinogenic amino acids usually show a characteristic connectivity pattern of cross 
peaks. Tyr can be readily identified by the NH-Hβ cross peaks where Hβs of Tyr3 have 
characteristic chemical shifts at 2.85 ppm and 3.24 ppm due to the aromatic effect. Lys5 
can be differentiated from Glu1 by cross peaks of NH-Hε and NH-Hδ  since Glu does not 
possess Hδ and Hε. The chemical shifts of Lys5Hε and Lys5Hδ are 2.97 ppm and 1.70 ppm 
respectively. Dpg2 and Dpg4 can not be identified using TOSCY spectra because the 
amide protons of Dpg2 and Dpg4 did not show any connectivities to the other protons in 
their individual spin systems due to the lack of alpha protons. 
The second step in the 1H NMR resonance assignment is to sequentially connect  
each amino acid residue to its neighboring ones using ROESY experiment.  The ROE 
cross-peaks between amide proton of residue i+1 and Hα of residue i can be observed in 







































Intraresidual TOCSY couplings                   Sequential ROESY couplings 






































Figure 2.12 Portion of 400 MHz TOCSY spectrum of EK-Dpg-Y in 30 mM phosphate 
buffer (H2O: D2O 9:1), pH 7.0 at 278 K 
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Amide protons of Dpg2 and Dpg4 can be identified through the sequential ROE couplings 
from the already identified neighboring amino acids.  The NH which has the chemical 
shift of 8.18 ppm shows ROE connectivities with Glu1NH and Glu1Hα, indicating this 
NH belongs to Dpg2. (Figure 2.13 and red arrows in Figure 2.11) The NH which has the 
chemical shift of 7.82 ppm shows ROE connectivities with Lys5NH and Tyr3Hα, 

























Figure 2.13 Portion of 400 MHz ROESY spectrum of EK-Dpg-Y in 30 mM phosphate 
buffer (H2O: D2O 9:1), pH 7.0 at 278 K. 
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The third step in 1H NMR resonance assignment of EK-Dpg-Y is to identity the 
four propyl groups from the two Dpg residues. The side chains of the two dipropyl 
glycine residues are indistinguishable using DQF-COSY, TOCSY and ROESY, thus 
HSQC, HSQC-TOCSY, and HMBC 2D experiments were performed to identify the four 
propyl groups. HMBC gives two cross peaks between amide proton of Dpg2 and its two 
Cβ at 38.9 ppm(side-chain A) and 36.4 ppm (side-chain B) respectively. This Cβ at 38.9 
shows a cross-peak with its Hγ and Hδ of Dpg2 residue at 0.67 from HSQC-TOCSY 
which enabled the assignment of propyl side chain A of Dpg2 residue. The Cβ at 36.4 
shows a cross-peak with its delta proton at 0.79 which allowed the assignment of propyl 
side chain B for Dpg2 residue. Two sets of diastereotopic protons from the beta carbons 
of propyl side-chain A and propyl side-chain B of Dpg2 reside were readily identified 
from HSQC spectra through the correlations of one bond 1H-13C coupling.  
HMBC displays a cross-peak correlating amide proton of Dpg4 to its Cβ at 37.0 
ppm. This Cβ displays a cross-peak with its gamma and delta protons of Dpg4 residue at 
1.12 and 0.88 respectively from HSQC-TOCSY which enabled the assignment for the 
two propyl groups of Dpg4 residue. The diastereotopic beta protons of propyl side-chain 
C and propyl side-chain D of Dpg4 are overlapping based on the integration of HSQC 
peak volume.  
 The C-terminal amide protons were determined from a cross-peak of Hα of Lys 
with a NH at 7.25 ppm using HMBC. The NH proton identified at 7.25 ppm had a cross-
peak in TOCSY with another amide proton at 7.58 ppm supporting an amide proton 
coupling pattern. Integration ratio of the two protons is 1:1. This correlation excludes the 
possibility of NH proton from the side-chain of Lys; because HMBC allows the 
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correlation at most 4 bonds away and thus the correlations between alpha proton of Lys 
with its side-chain NH3 are too far away to be observed. Overlaps were observed for the 
alpha carbons of Glu and Tyr, Cα of residue 2 (Dpg2) and residue 4 (Dpg4) respectively in 
HSQC spectra. HSQC–TOCSY further confirms the assignments by enabling us to see 
one bond 1H-13C coupling throughout an entire spin system. The 1H resonance chemical 
shift assignments, coupling constants and 13C resonance chemical shift assignments for 
EK-Dpg-Y are summarized in Table 2.3 and Table 2.4 respectively. 
Table 2.3 1H Chemical shiftsa and coupling constants of EK-Dpg-Y peptide in phosphate 
buffer, pH 7.0, at 278 K 
Residues NH Hα Hβ Others 3JHNHα 
Acety0    CH3 2.10  
Glu1 8.60 4.06 1.94 
2.02 
Hγ 2.31 5.0 
Dpg2 8.18 ― 1.43, 1.59 
1.71, 1.84 
Hγ 0.67, Hδ 0.67 
Hγ 1.04, Ηδ 0.79 
— 
Tyr3 7.71 4.56 2.85 
3.24 
Hδ 7.18, Hε 6.85 6.9 
Dpg4 7.82 ― 1.78 
1.93 
Hγ 1.12, Hδ 0.88 — 
Lys5 8.07 4.22 1.92 
1.79 





    
aChemical shifts are referenced to internal DSS at 0 °C, pH 7. 
 
Table 2.4 13C Chemical shifts for EK-Dpg-Y 
13C Chemical Shift (ppm) Residue 
C=O Cα Cβ Cγ Cδ Cε Cζ 
Acetyl 177.2 24.0                                                    
Glu1 176.4 58.0 29.4 36.0 182.0                     







Tyr3 175.2 58.0 37.8 130.0 132.0 118.0 155.0 







Lys5 179.4 56.0 31.8 24.8 28.4 41.6            
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2.2.5 Conformational Analysis by NMR 
2.2.5.1 Chemical Shift Deviations 
The assignments of  1H chemical shifts for the EK-Dpg-Y peptide are summarized 
in Table 2.3. Those for the Hα in peptides are well-known to be highly conformationally 
dependent. In helical and turn conformations, α-protons exhibit an upfield shift with 
respect to random coil conformation whereas a downfield shift indicates of a β-sheet 
structure.40 Chemical shift deviations of Hα and NH from random coil values for the EK-
Dpg-Y and EK-Dpg-V are summarized in Table 2.5. Hα  of both EK-Dpg-Y and EK-
Dpg-V experience upfield shift, suggesting that the EK-Dpg-Y and EK-Dpg-V may adopt 
helical or turn conformations. However the effects of ααAAs on  Hα chemical shifts have 
not been fully studied, chemical shift data alone are not enough to provide the 
information on the nature of the conformations. 
Table 2.5 Ηα and NH NMR chemical shift deviation for EK-Dpg-Y and EK-Dpg-Va 
 EK-Dpg-Y 
Residue Ηα  CSD  (∆δ, ppm)b NH CSD  (∆δ, ppm)c  
Glu -0.28 0.03 
Tyr -0.02 -0.53 
Lys -0.09 -0.40 
 EK-Dpg-V 
Glu -0.16 0.13 
Val -0.21 -0.37 
Lys -0.13 -0.34 
a. since Dpg is not standard proteinic residue, and has no Hα, there are no reference 
values for which CSD can be computed. 
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b. Hα chemical shift deviations were calculated from peptide data at 25 ºC and random 
coil data at 25 ºC from Wishart et al.41  
c. NH chemical shift deviations were calculated from peptide data at 25 ºC and random 
coil data at 25 ºC from Wishart et al.41  
 
Carbon chemical shifts of Cα and carbonyl carbons are conformationally sensitive 
and these shifting tendencies for carbon nuclei are opposite in direction to those found for 
the α and amide protons, with residues in helical structures showing downfield shifts and 
with residues in β-sheet showing upfield shifts relative to random coil conformation.  
Chemical shift deviations of α- and carbonyl carbon from random coil values for the EK-
Dpg-Y are summarized in Table 2.6. Both α-carbon and carbonyl carbons of EK-Dpg-Y 
display downfield shift, suggesting that the EK-Dpg-Y may adopt helical or turn 
conformations. 
Table 2.6 α-Carbon and carbonyl carbon NMR chemical shift deviations for EK-Dpg-Ya 
 EK-Dpg-Y 
Residue Cα  CSD(∆δ, ppm)a C=O  CSD (∆δ, ppm)a 
Glu 3.1 2.0 
Tyr 2.4 0.4  
Lys 0.8 3.2 
a. Cα and C=O chemical shift deviations were calculated from peptide data at 5 ºC and 
random coil data at 25 ºC from Wishart et al.41  
 
2.2.5.2  Amide Proton Temperature Coefficients 
The temperature dependence of amide proton chemical shifts (temperature 
coefficients) are frequently measured to provide valuable information on intramolecular 
hydrogen-bonding formation. Hydrogen-bonded NHs typically display reduced 
temperature coefficients with respect to those in random coil structures.42 Temperature 
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coefficients of NH resonances for EK-Dpg-Y are shown in Table 2.7. The Dpg2 residue 
has ∆δ/∆Τ of -7.8, while Dpg4 has ∆δ/∆Τ of -3.4. The substantial difference of 
∆δ/∆Τ values between them and the small absolute values of ∆δ/∆Τ of the Dpg4 N-H 
suggest that it may participate in the formation of the hydrogen bond. In addition, the 
chemical shifts of amide protons involved in hydrogen bonding experience upfield shift 
with respect to the amide protons exposed to water.43 The amide proton chemical shift of 
Dpg4 at 7.82 ppm is significantly upfield shifted compared to Dpg2 amide proton at 8.18. 
The Tyr3 NH possesses a reduced temperature coefficient compared to the random coil 
temperature coefficient of -9.32 and the amide proton of Tyr3 shows significant upfield 
shift from random coil by 0.53 ppm as shown in table 2.5, thus indicating it may also 
form of a hydrogen bond.  
Table 2.7 Temperature coefficients of NH resonances for EK-Dpg-Y in phosphate buffer, 
pH 7.0 
     EK-Dpg-Y  Observed ∆δ/∆T (ppb/K) Reported Random Coil  
∆δ/∆T  (ppb/K) 
Glu1 -7.2 -7.01 
Dpg2 -7.8 _ 
Tyr3 -5.8 -9.32 
Dpg4 -3.4 _ 








Table 2.8 shows the temperature coefficients of N-H resonances for KE-Dpg-Y. 
The Dpg2 residue has ∆δ/∆Τ of -7.2, while Dpg4 has ∆δ/∆Τ of -4.5. The 
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∆δ/∆Τ difference between the two residues is 2.7 which is much smaller than the 
difference of 4.4 in EK-Dpg-Y, suggesting Dpg4 NH in KE-Dpg-Y may be accessible to 
the solvent. The Tyr3 N-H has a lowered temperature coefficient of -5.3 compared to the 
random coil temperature coefficient of -9.32, thus indicating it may participate in 
intramolecular hydrogen bonding. The 1H NMR spectra of amide NH for EK-Dpg-Y and 
KE-Dpg-Y over the temperatures of 278 K to 303 K are shown in Figure 2.14 and Figure 
2.15 respectively. 
Table 2.8 Temperature coefficients of NH resonances for KE-Dpg-Y in phosphate buffer 
      KE-Dpg-Y  Observed ∆δ/∆T (ppb/K) Reported Random Coil 
∆δ/∆T (ppb/K) 
Lys1 -8.0 -7.87 
Dpg2 -7.2 _ 
Tyr3 -5.3 -9.32 
Dpg4 -4.5 _ 






Table 2.9 illustrates the temperature coefficients of N-H resonances for EK-Dpg-
V. The valine NH has a reduced temperature coefficient of -5.5 compared to the random 
coil temperature coefficient of -8.35; however, the difference between them is only 2.85, 
suggestive of a moderately solvent shielded proton. The temperature coefficients of NH 
resonances for EK-Aib-Y are given in Table 2.10. The temperature coefficients of Tyr3 
















Figure 2.14 400 MHz 1H NMR of amide NH of 10 mM EK-Dpg-Y in 30 mM phosphate 




















Figure 2.15 400 MHz 1H NMR of amide NH of 10 mM KE-Dpg-Y in 30 mM phosphate 







Table 2.9 Temperature coefficients of NH resonances for EK-Dpg-V in phosphate buffer, 
pH 7.0 
      EK-Dpg-V   Observed ∆δ/∆T (ppb/K) Reported Random Coil 
∆δ/∆T (ppb/K) 
Glu1 -6.5 -7.01 
Dpg2 -8.0 _ 
Val3 -5.5 -8.35 
Dpg4 -9.2 _ 


































Table 2.10 Temperature coefficients of NH resonances for EK-Aib-Y in phosphate 
buffer, pH 7.0 
      EK-Aib-Y Observed ∆δ/∆T (ppb/K) Reported Random Coil 
∆δ/∆T (ppb/K) 
Glu1 -5.8 -7.01 
Aib2 -7.2 _ 
Tyr3 _ -9.32 
Aib4 -4.1 _ 








2.2.5.3  NOE Connectivities 
The NOE connectivities provide information on the types of conformations present in 
solution because different peptide conformations are associated with specific patterns of 
NOE connectivities.44 Sequential dNN(i,i+1) NOE connectivities, medium-range NOE 
connectivities dαN(i,i+2), and dαN(i,i+3) are observed, if the peptide has a significant 
population of turns or helices. Whereas strong sequential dαN(i,i+1) NOE connectivities 
with the absence of dNN(i,i+1) NOEs are observed if the peptide adopts an extended 
conformation.32 The NH-NH region of the ROESY spectrum and the Hα-NH region of 
the 2D ROESY NMR spectra for EK-Dpg-Y are shown in Figure 2.16 and 2.17 
respectively. EK-Dpg-Y shows strong sequential dNN (i,i+1) NOE connectivities 
throughout the entire sequence of this peptide indicating the presence of the helical 
conformation (Figure 2.16). Medium-range NOEs dαN (i,i+2) between the residue Glu1 
and Tyr3, between CH3 of acetyl group and Dpg2, medium-range dαN (i,i+3) NOE 
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between the Glu1 and Dpg4 (Figure 2.17) are observed, indicating significant population 
of turn or helical backbone conformation. The cross-peaks of dαN(2, 4)  between Glu and 
Tyr and cross-peak between acetyl CH3 proton and Dpg2 NH and  reduced temperature 
coefficient of Tyr3 NH indicate a β-turn structure from acetyl to Tyr3 with an 
intramolecular 4→1 hydrogen bonding between the acetyl carbonyl oxygen and Tyr3 NH. 
The cross-peak of dαN(1, 4)  between Glu1 and Dpg4 and reduced temperature coefficient 
of the Dpg4 NH suggest another β-turn from residue Glu1 to Dpg4 with a presence of a  
4→1 hydrogen bonding between carbonyl of Glu1 and Dpg4 NH. The pattern of NOE 
connectivities for EK-Dpg-Y is identical at both 278 K and 298 K, suggesting that the 
solution structure of EK-Dpg-Y is stable over temperatures and the high population of the 
structure is still preserved at higher temperature 298 K.  
Glu1

















Figure 2.16  NH-NH region of the 400 MHz ROESY spectrum of 10 mM EK-Dpg-Y in 
30 mM phosphate buffer (H2O: D2O 9:1), pH 7.0 at 278 K. A spin-lock mixing time of 


















Figure 2.17 Ηα-NH region of the 400 MHz ROESY spectrum of 10 mM EK-Dpg-Y in 
30 mM phosphate buffer (H2O: D2O 9:1), pH 7.0 at 278 K. A spin-lock mixing time of 










The observed NMR NOEs for EK-Dpg-Y are summarized schematically in Figure 2.18. 








                        Strong         Medium                  Weak 
Figure 2.18  Summary of ROEs for EK-Dpg-Y. The thickness of the lines reflects the 
relative NOE intensities. dNN refers to the NH-NH ROE, dαN refers to the Hα-NH ROE, 
dRN refers to side chain-NH ROE, dRα refers to side chain-Hα ROE and dRR refers to side 












EK-Dpg-V shows sequential dNN (i,i+1) NOEs over the entire sequence of this 
peptide suggesting backbone dihedral angles are in the helical or turn region of 
conformational space (Figure 2.19) which is consistent with the CD result.  The medium-
range NOE dαN (i,i+2) between the residue Val3 and Lys5 is also observed (Figure 2.20); 
however, the other medium-range NOEs can not be assigned because the overlap of Glu 
and Lys alpha protons. 
KE-Dpg-Y shows strong sequential dαN(i,i+1) NOEs over the entire length of the 
sequence and only one sequential dNN (i,i+1) NOE between Lys1 and Dpg2 as shown in 
Figure 2.21 and Figure 2.22. This peptide also exhibits no medium-range Hα-NH NOEs 
(Figure 2.22) suggesting it is less structured than EK-Dpg-Y which is in good agreement 
with the CD results of this peptide. In EK-Dpg-A, NH-NH NOEs between Dpg2 and 
Ala3, between Lys and C-terminal NH are the only two NOEs identifiable because of the 
overlapping of the amide protons of Ala3, Lys5 and Dpg4, and also some of the NOEs are 
too proximate to the diagonal to be assigned unambiguously as shown in Figure 2.23. The 
complete overlap of Hαs of Glu, Ala and Lys makes the assignment of Hα-NH NOEs 
impossible in this peptide as illustrated in Figure 2.24. In EK-Aib-Y, the observation of 
the strong sequential dαN (i,i+1)  NOEs between Glu1 and Aib2, between Tyr3 and Aib4,  
and between Lys5 and NH of C-terminus indicating that  backbone dihedral angles are in 
the β-sheet region of conformational space as shown in Figure 2.26. The two NOEs in the 
NH-NH region can not be assigned unambiguously due to the overlap of amide protons 
of Tyr3 and Lys5 as illustrated in Figure 2.25. 
The NOE connectivities other than NH-NH and Ηα-NH NOEs observed for the 
peptides KE-Dpg-Y, EK-Dpg-V, and EK-Aib-Y are as follows: In KE-Dpg-Y, strong 
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medium range NOEs between CH3 of acetyl0 and Tyr3Hδ,  between CH3 of acetyl0 and 
Tyr3Hε, between Dpg2Hγ, Hδ with Tyr3Hδ and Tyr3Hε  respectively were observed, NOE 
between Dpg4Hγ and Tyr3Hδ was also observed. In EK-Dpg-V, NOEs from the Dpg side 
chains and Val side chain can not be assigned unambiguously due to the overlap between 
Dpg2Hγ and Val3Hγ and the overlap between Dpg2Hβ, Dpg4Hβ and Lys5Hβ. In EK-Aib-Y, 
NOEs between two Aib2Hβ and Tyr3Hδ, and only one Aib4Hβ and Tyr3Hε were observed, 





















Figure 2.19 NH-NH region of the 400 MHz ROESY spectrum of 10 mM EK-Dpg-V in 
30 mM phosphate buffer (H2O: D2O 9:1), pH 7.0 at 278 K. A spin-lock mixing time of 















Figure 2.20 Ηα-NH region of the 400 MHz ROESY spectrum of 10 mM EK-Dpg-V in 
30 mM phosphate buffer (H2O: D2O 9:1), pH 7.0 at 278 K. A spin-lock mixing time of 









Figure 2.21 NH-NH region of the 400 MHz ROESY spectrum of 10 mM KE-Dpg-Y in 
30 mM phosphate buffer (H2O: D2O 9:1), pH 7.0 at 278 K. A spin-lock mixing time of 































Figure 2.22 Ηα-NH region of the 400 MHz ROESY spectrum of 10 mM KE-Dpg-Y in 
30 mM phosphate buffer (H2O: D2O 9:1), pH 7.0 at 278 K. A spin-lock mixing time of 








































Figure 2.23 NH-NH region of the 400 MHz ROESY spectrum of 10 mM EK-Dpg-A in 
30 mM phosphate buffer (H2O: D2O 9:1), pH 7.0 at 278 K. A spin-lock mixing time of 










Figure 2.24 Ηα-NH region of the 400 MHz ROESY spectrum of 10 mM EK-Dpg-A in 
30 mM phosphate buffer (H2O: D2O 9:1), pH 7.0 at 278 K. A spin-lock mixing time of 







































Figure 2.25  NH-NH region of the 400 MHz ROESY spectrum of 10 mM EK-Aib-Y in 
30 mM phosphate buffer (H2O: D2O 9:1), pH 7.0 at 278 K. A spin-lock mixing time of 































Figure 2.26 Ηα-NH region of the 400 MHz ROESY spectrum of 10 mM EK-Aib-Y in 30 
mM phosphate buffer (H2O: D2O 9:1), pH 7.0 at 278 K. A spin-lock mixing time of 400 







2.2.6 Structural Analysis of EK-Dpg-Y 
The optical spectra, CD and VCD are consistent in suggestion that the EK-Dpg-Y 
pentapeptide has a partially helical or turn-like structure. The NMR Hα chemical shifts, 
Cα and C=O chemical shift are consistent with helical or turn conformations and the N-H 
temperature dependence NMR analysis(∆δ/∆Τ) further confirms the Tyr3 and Dpg4 
residues are H-bonded with N-terminal acetyl carbonyl and Glu1 carbonyl respectively. 
Our data for NOE values and coupling constants can further be used to constrain a 
normal NMR structure analysis. 
 Structures calculated by MD simulated annealing using experimental restraints 
from the ROE and HNHA data superimpose well for the backbone atom positions from 
the N-terminus until the C-terminal Dpg4 residue, as shown for the low variance in the φ 
dihedral angle for the Glu1, Dpg2 ,Tyr3 and Dpg4 residues noted in Table 2.11. The 
overlay of side-chains follows a similar pattern where Glu1, Dpg2, Tyr3, and Dpg4 are 
well structured while Lys5 seems flexible and unstructured with side-chains having no 
particular conformation as shown in Figure 2.27. The Tyr3 ring packs tightly against 
Dpg2 and is well structured indicating that there is a strong hydrophobic interaction of the 
Tyr3 side-chain and the pro-S propyl side chain of Dpg2. This hydrophobic interaction 
may be a strong stabilizing force of the peptide folding in water. The order in the 
ensemble for the N-terminal Ace0 is due to packing with Tyr3 as well. Backbone 
hydrogen bonds found between the NH of Tyr3 and the carbonyl of the Ac group and 
between NH of Dpg4 and the carbonyl of Glu1 most likely play a critical role in the 
stability of this peptide turn as illustrated in Table 2.12.  
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Figure 2.27 Overlay of 10 structures of the EK-Dpg-Y calculated from ROE restrained 
molecular dynamics simulated annealing. a: side view, b: top view. Each residue is 
displayed in the different color: Ace0(black), Glu1(red), Dpg2(green), Tyr3(blue), 












The secondary structure for the mean was evaluated within MOLMOL and is 
found to adopt a short 310-helix from residues 0-4, while the C-terminus is frayed. This is 
evident from the cyan colored backbone trace in Figure 2.27b.  A comparison of the 
average torsional angles for the 10 lowest energy structures(Table 2.11) and the apparent 
H-bond lengths(Table 2.12) also illustrate that the ordered region of the peptide adopts a 
helical structure.  
 
Figure 2.28 The Ramachandran plot of EK-Dpg-Y 
The Ramachandran plot of EK-Dpg-Y is shown in Figure 2.28, which gives 
possible conformations of φ and ψ dihedral angles. All of the dihedral angles φ and ψ for 
EK-Dpg-Y are in the right-handed helical region of conformational space. 
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Table 2.11  Average dihedral angles, standard deviations are given in parentheses.  An 
angle τ represents N-Cα-C(O) angle 
 
 Glu1 Dpg2 Tyr3 Dpg4 Lys5 
φ -62.5 (1.3) -49.1 (4.3) -90.0 (2.8) -51.1 (3.4) -111 (8.1) 
ψ -31.7 (3.4) -30.0 (5.7) -53.1 (5.5) -39.1(2.8) 19.1 (3.5) 
χ1     -69.2  (45) 47.8 (37) 
81.2 (48) 
-47.1 (3.4) 43.6 (53) 
-170 (37) 
-61.2 (3.7) 
χ2     -173   (4.3)    -158  (93)  -178 (39) 
χ3     -3.50  (92)    -177 (69) 
χ4     164  (48) 
χ5     -78  (99) 
χ6   -178 (117)   
τ 111(0.31) 113(0.68) 111(0.15) 112(0.82) 111(0.18) 
 
 
Table 2.12  Backbone H-bonds and the distance between the ring group of Tyr3 and the 
side chain of Dpg2 
 Distance Å 
O (Ac) – HN (Tyr3) 2.37  (0.28) 
O (Ac) – HN (Dpg4) 3.15 (0.90) 
O (Glu2) – HN (Dpg4) 2.59 (0.43) 
O (Glu2) – HN (Lys5) 3.00 (1.28) 
Cγ1 (Dpg2) - Cγ (Tyr3) 4.18 (0.49) 
 
 
X-ray crystallography studies suggest that most peptides containing Dpg  favor 
helical conformations and only a few favors extended structures.21-23, 26-30 Karle et al. 
showed that when incorporated into a poor helix promoting sequence, the hexapeptide 
Boc-Gly-Dpg-Gly-Gly-Dpg-Gly-NHMe adopts a helical conformation in crystal 
structure.21 The substantial retention of the helical conformation was observed in apolar 
solvent CDCl3, whereas, in the strongly solvating solvent DMSO, an unfolded 
conformation was observed based on NMR data. The helical conformation is stabilized 
by the intramolecular hydrogen bonding involving residues 4-6 and the terminal NHMe 
in CDCl3. The unfolded structure in DMSO is due to the solvent invasion which 
destabilizes intramolecularly hydrogen bonded backbone conformations indicated by the 
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high temperature coefficients (∆δ/∆Τ). This suggests that solvents play an important role 
in the formation of the peptide conformation.  
Dpg coupled to the highly helical promoting alanine in the tripeptide Boc-Ala-
Dpg-Ala-OMe adopts a helical conformation in crystal state, whereas in DMSO the 
tripeptide adopts extended conformation.18, 24 It suggests that differences between solid 
and solution state conformation do occur. Herein, we present the first reported use of 
aqueous solutions in elucidating secondary conformations of Dpg containing peptides. 
Theoretical calculations reveal a strong dependence on the bond angle N-Cα-CO 
(τ) with τ >105° favoring helical conformations and τ <105° favoring extended 
conformations.45-47 The crystal structures of Dpg containing peptides have also been 
shown to have  τ angles in this range. Indeed the MD simulated annealing gave the τ 
angles of the two Dpg residues for EK-Dpg-Y larger than 110° as illustrated in Table 
2.11, which indicates that these residues are in the helical conformation. 
2.3 Conclusions 
 In conclusion, CD, VCD and NMR spectral analysis suggest that Dpg containing 
peptides adopt more ordered structures relative to their Nva containing analogues. The 
central residues (Ala, Val, Thr, Tyr) and the charged side-chains of Glu and Lys play 
important roles in the degree of peptide folding. Hydrophobic and branched residues (Val, 
Tyr) at the central position of the peptide produce greater folding as judged by CD and 
NMR. Despite the high tendency of Aib to induce helical conformation, CD and NMR 
data suggest that EK-Aib-Y is less structured compared to EK-Dpg-Y. This suggests that 
the stabilizing force for the pentapeptide EK-Dpg-Y folding in water may arise from 
strong hydrophobic interaction between side-chains of Dpg2 and Tyr3 rather than the 
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amino acid propensity for helical conformations. Temperature-dependent NMR analysis 
of NH resonances (∆δ/∆Τ) for Ac-Glu-Dpg-Tyr-Dpg-Lys-NH2 suggests a series of 
i→i+3 hydrogen bonds between the N-terminal acetyl carbonyl and the Tyr3 NH, and the 
Glu1 carbonyl and the Dpg4 NH. The solution conformation of Ac-Glu-Dpg-Tyr-Dpg-
Lys-NH2 calculated from NMR-derived restraints shows a 310-helical structure (two 
repetitive type-III β-turns), which is supported by 2D NMR, CD and VCD spectra. 
Analysis of NMR-derived models of these peptides suggest that there is a strong 
hydrophobic interaction of the pro-S propyl side chain of Dpg2 and the Tyr3 side-chain 
that may be a strong stabilizing force of the peptide folding in water.   
2.4 Experimental 
• Synthesis and Purification of Peptides 
 
Peptides were synthesized using standard solid-phase Fmoc chemistry on Fmoc-
PAL-PEG-PS resin (Applied Biosystems) in continuous-flow mode on an Applied 
Biosystems Pioneer peptide synthesizer. The primary sequences of Dpg and Nva 
containing peptides are listed in Table 2.1. 
The Fmoc amino acids utilized were Fmoc-Glu(tBu)-OH, Fmoc-Dpg-OH, Fmoc-
Tyr(tBu)-OH, Fmoc-Lys(Boc)-OH, Fmoc-Ala-OH, Fmoc-Val-OH, Fomc-Thr(tBu)-OH,  
Fmoc-Nva-OH and Fmoc-Aib-OH. Deprotection of Fmoc group was achieved using 
Reagent B (Piperidine-DBU-DMF, 2:2:96 v/v). The step-wise coupling of each amino 
acid was performed in DMF using 4 eq of amino acids, 4 eq of PyAOP, and 8 eq of 
DIEA. Couplings for Dpg containing peptides were performed at an elevated temperature 
of 50ºC due to the difficult coupling of the Dpg to the peptide sequence. Acetylation of 
the N-terminus of Dpg and Nva peptides was carried out via manual synthesis, where the 
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resin was treated with excess 0.2 M of Ac2O in 0.28 M of DIEA/DMF solution (16 equiv) 
for 2 h, followed by rinsing with DMF and DCM, the resin was dried under high vacuum 
for 4h. The peptide was cleaved off the solid support with concomitant deprotection of 
side chains using standard cleavage solution (trifluoroacetic acid-triisopropylsilane-
water-phenol, 88:2:5:5 v/v) for 2 hours.  
• TFA-Mediated Peptide Cleavage 
Precipitation Method: the resulting filtrate was precipitated with cold ether overnight. 
The precipitate was then washed with cold diethyl ether and centrifuged at 40, 000 rpm 
for ten minutes (3 x). Ether was decanted off and the pellet was allowed to dry under high 
vacuum for 5 hours to yield the crude peptide. 
Extraction Method: the resulting filtrate was diluted with cold 30% acetic acid solution, 
washed with cold diethyl ether (3 x 50 mL), and lyophilized to yield the crude peptide. 
Crude peptides were purified by reverse-phase high-performance liquid 
chromatography (HPLC) on a Waters Delta-Pak C18 column (15 µm, 300Å, 8 x 100 mm) 
with a gradient from 90% A (H2O, 0.1%TFA) and 10% B (CH3CN, 0.1% TFA) to 30% A 
and 70% B over 60 mins at a flow rate of 1mL/min. Semi preparative conditions were 
carried out using a Waters preparative Delta-Pak C18 column (15 µm, 300 Å, 25x100 mm)  
at a flow rate of 20 mL/min. The homogeneity (> 99%) was confirmed by analytical 
reverse-phase HPLC monitoring at the wavelength of 220 nm with the scan wavelength 
from 200 to 400 nm  using a Vydac C18 column (5 µm, 4.6 x 250 mm) and identity of the 
peptides was determined by matrix-assisted laser desorption ionization-time of flight 
(MALDI-TOF) on a Bruker Proflex III instrument with XMASS software Net peptide 
concentration determined by quantitative amino acid analysis. Amino acid analysis was 
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performed on a Dionex AAA-Direct system composed of a GS50 Gradient Pump, an 
AS50 Autosampler, and an ED50 Electrochemical Detector.   
Table 2.13 Analytical HPLC retention time and corresponding MALDI results 
Peptide             Retention time(min)                          MALDI (M+H)+ m/z 
                                                                            Calculated                  observed 
EK-Dpg-Y              37.1                                        762.9                        762.4 
KE-Dpg-Y              25.0                                        762.9                        762.9       
EK-Dpg-A              46.7                                        670.8                        671.1    
EK-Dpg-V              43.8                                        698.5                        698.2 
EK-Nva-A              37.1                                        586.4                        585.8 
EK-Nva-V              37.9                                        614.7                        614.4 
EK-Aib-Y               27.6                                        650.7                       650.4 
 
• Circular Dichroism Spectroscopy  
CD spectra were recorded on an Aviv 60DS circular dichroism spectrometer with 
Igor plotting software using a 1mm path-length quartz cell for samples. The CD spectra 
are averages of three scans, collected at 1.00 nm intervals from 250 to 190 nm, recorded 
at 20 °C. Samples were prepared by dilution of a stock solution of peptide sample (~1 
mM) in phosphate buffer (10 mM, pH =7) to acquire the working solution of 100-500 
µM peptide concentration. All spectra were corrected by subtraction of the buffer 
background and are presented as molar ellipticity [θ] in units of (deg cm2 dmol-1).  
• Infrared Absorption and Vibrational CD 
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IR spectra were obtained on an FTS-60A (Digilab/Varian Randolf, MA) FTIR for 
peptides that were lyophilized from 10% DCl (to remove TFA) and redissolved in D2O 
based 0.01 M phosphate buffer. Samples were placed in a demountable cell (homemade) 
with CaF2 windows separated by a 50 or 100 µm spacer.  A pathlength(spacer) of 100 µm 
was used. Temperature was controlled by flow from a software controlled bath (Neslab 
RTE 11). 
VCD spectra were obtained on a dispersive instrument, whose design and 
operation are detailed in the literature,48 using the same samples and cells.  VCD spectra 
of these peptides were very weak, are the average of 8 scans with a 10 sec time constant 
and needed optimized correction for baseline (obtained from identical scans of just buffer 
in a similar cell) to reveal the amide I pattern.  
• NMR Spectroscopy 
 NMR data for EK-Dpg-Y was acquired from 13.6 mM EK-Dpg-Y in 30 mM 
potassium phosphate buffer (H2O: D2O 9:1) with 0.05 mM DSS as internal NMR 
chemical shift reference standard. All experiments were performed at 278 K on a Bruker 
DPX operating at 400 MHz. The COSY, TOCSY, and ROESY experiments were 
acquired with spectral widths of 4800*4800 Hz and 2048*512 complex acquisition points 
in the direct and indirect dimensions respectively. All spectra were zero filled once in the 
t1 dimension and weighted by a square cosine bell function. Several TOCSY spectra 
were recorded with 16 transients per increment and mixing times of 18, 36, 72 and 144 
ms.49 The ROESY experiment was recorded with 56 scans per increment and a mixing 
time of 400 ms. 
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Two dimensional HSQC, HSQC-TOCSY and HMBC spectra were collected on a 
Varian INOVA with a proton Larmor frequency of 500 MHz. Water suppression for the 
HSQC and HSQC-TOCSY was accomplished through 'WET'.50  Spectral widths are 
8000Hz*21400Hz for proton and carbon dimension, respectively and were acquired with 
2400*512 complex points, with 64 scans per increment.  Also, an 80ms spin lock was 
used for the HSQC-TOCSY.  Gaussian line broadening was used for each of these 
spectra as well as having used linear prediction in t1 for the HSQC-TOCSY. The HMBC, 
were recorded with spectral widths of 6500*30200 Hz for proton and carbon dimensions, 
respectively along with 2048*1024 complex points and 48 scans per increment.  Linear 
prediction was performed once in the carbon dimension while a Gaussian window 
function was used for line broadening. Long range coupling constants 10 Hz and 6 Hz are 
used, respectively. Long range coupling constants are important parameters for HMBC. If 
they are set incorrectly, the long range coupling cross peaks may disappear. The difficult 
part here is that the long range coupling constants are not fixed but variable in a range. 
Therefore we choose 2 constants to get needed information, which is not available from 
using just one constant value. 
The temperature coefficients of the amide protons were measured by collecting a 
series of 1D spectra on a Bruker DPX operating at 400 MHz. The spectra were recorded 
at six different temperatures ranging from 5 °C to 30 °C in 5 deg increments.  All spectra 
were processed using XWINNMR 2.6 on a Silicon Graphics computer. 
• Structure Calculationsa 
The ROESY experiments yielded a total of 59 interproton distance restraints 
which were classified into upper bounds of 3.5, 4.5 and 6.0 Å depending on cross peak 
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volumes and are calibrated from fixed atomic distances within the molecule.  A lower 
bound of 1.8 Å was used in all cases as well.  Additionally, a single φ restraint was 
determined from the HNHA data based on the criteria (φ = -120 ± 45° if 3JHNHα >7.5 Hz;  
φ = -50 ± 45° if 3JHNHα <6.0 Hz).    
For incorporation of Dpg into simulated annealing procedure employed for NMR 
structure determination, a new monomer needed to be created. The extended 
conformation of a Dpg containing peptide crystal structure (CSD refcode: WOZZIL) was 
used as a starting point.  This extended structure was used to obtain RESP charges by 
using Gaussian 03 and RESP program in AMBER 8 package. 
 An extended model of EK-Dpg-Y was built within the LEAP module of AMBER.   
Partial charges for the Dpg residue were obtained by employing a restrained electrostatic 
potential (RESP), which is consistent with the Amber force field (ff99sb).51,52 All 
subsequent molecular dynamics (MD) calculations were performed using a generalized 
Born continuous solvation model.53  
 A total of 500 starting structures were generated in AMBER 8, by running 
unrestrained MD for 3ps, during which the temperature is ramped to 300 K and then back 
down to 20 K.  Next the structures were subjected to a round of restrained simulated 
annealing for 20 ps, during which the temperature was ramped to 1000 K (8 ps) and then 
cooled to 0 K (12 ps).  The experimentally derived restraints were ramped from 20% to 
full value during the first 12 ps and held at full value until the end of the run.  During the 
calculations, the NOE distance, 3J dihedral and the ω constraints were applied with force 
constants of 20 kcal mol-1 Å-1, 500 kcal mol-1  rad -2, 1000 kcal mol-1  rad -2, respectively. 
Bond angle and chirality restraints were also applied at a constant value of 1000 kcal mol-
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1  rad -2 throughout the simulation. The simulated annealing protocol was repeated twice 
more for a total production run of 60 ps.  The 10 unique structures with the lowest 
AMBER and restraint violation energies were then selected for further analysis.  The 
program Suppose was used to overlay the structures which were found to be well ordered 
(r.m.s. deviation of 0.29 Å for backbone heavy atoms).  The graphics were generated 
with the program MOLMOL.54 
a Structure calculations were performed by Dr. Dan McElheny at UIC. 
 
Table 2.14 Structure determination statistics                                                    
 
NMR restraints 
Distance restraints     41 
   Intraresidue      18 
   Sequential (|i-j|=1)     14 
   Medium range (1<|i-j|≤4)    9 
   Long range (|i-j|>4)     0 
   Ambiguous      0 
Torsion angle restraints     
   φa       1 
 
Structure statistics (10 structures) 
Energies 
   Mean AMBER energy    -177±16 kcal mol-1 
   Mean restraint violation energy   7±1 kcal mol-1 
R.m.s deviations from ideal covalent geometry 
   Bond lengthsb     0.012 Å 
   Bond anglesb      1.78° 
Ramchandran statisticsc 
   Most favored     86.7 
   Allowed      13.3 
   Disallowed      0.0 
Atomic r.m.s deviations (Å)-1 
   Backbone atoms     0.11 
   All heavy atoms     0.56 
                                                                                                                                  
 aDetermined from 3J measurements. bTorsional and distance restraint violations.  cAs 
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SYNTHESIS AND EVALUATION OF α,α-DISUBSTITUTED AMINO ACIDS AS 
β-SHEET STABILIZING FACTORS 
 
3.1  Introduction 
 
A number of diseases arise by protein misfolding from a native structure to a 
predominantly β-sheet conformation. These protein conformational diseases include 
Alzheimer’s disease (AD), type II diabetes, Parkinson’s disease and prion disorders. In 
all these diseases  the misfolded protein self-aggregates to amyloid fibrils and deposits as 
amyloid plaques in organs promoting tissue damage and organ dysfunction.1-5 An 
increased understanding of what factors control or stabilize β-sheet structures may lead to 
valuable insights into the underlying causes of these diseases and suggest possible 
treatments for such protein misfolding disorders.6-8  
            Following protocols previously developed in the Hammer laboratory,                    
α,α-diisobutylglycine (Dibg) was synthesized via palladium catalyzed allylic alkylation 
of ethyl α-nitroacetate with 2-methylallyl acetate and incorporated into various positions 
of a model β-hairpin peptide GHP, in order to determine the effectiveness of the 
tetrasubstituted amino acids as design elements in both the strand and turn portions of β-
hairpins. β-Hairpins contain two-stranded antiparallel β-sheets connected by a two 
residue loop. β-Hairpins represent minimum increments of a β-sheet and therefore 
provide an excellent model system for evaluating the fundamental aspects of β-sheet 
formation and stabilization in isolated, well-defined molecular systems. Two novel 
peptides Leu3-NG and Dibg3-NG were also synthesized to investigate their ability to 
stabilize the β-hairpin peptides. 
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 As part of our effort for understanding of the role of ααAAs on β-sheet 
propensity and adding to our ability to make peptide analogues of predictable structure, 
novel chiral ααAAs with bulky hydrophobic side chains, suitably protected for peptide 
synthesis, were synthesized via the catalytic approach. The synthesis of most chiral 
amino acids involve the use of chiral templates.9, 10  This methodology requires the use of 
stoichiometric quantities of chiral template, which can cause difficulties in the  
preparation of highly functionalized ααAAs, due to incompatibility of conditions for 
template removal with existing side-chain protecting groups. Furthermore, preparative 
scale reactions to yield gram amounts of material for peptide synthesis are often 
expensive with template approaches. In contrast to utilizing chiral templates, the phase-
transfer catalyst approach offers advantages, such as mild conditions, minimization of 
protection and deprotection chemistries,  and the ability to scale up reactions.11 Herein 
several chiral ααAAs were synthesized via the enantioselective phase-transfer catalytic 
alkylation of a Schiff base substrate in the presence of (S,S) –binaphthyl quaternary 
ammonium salt to streamline the synthesis of highly functionalized ααAAs.12 
3.2  Results and Discussion 
 3.2.1  Molecular Modeling of Dibg-Containing Peptide 
We modeled the peptide Ac-Val-Dibg-Ala-NHMe by first setting the peptide to a 
representative β-sheet conformation with φ = −125, ψ  = 125,  locking these angles for 
the Val (φ1,ψ1) and Ala (φ3,ψ3)  residues.  Then the peptide was subjected to 200 cycles 
of simulated annealing.  The low energy structure for each cycle of annealing was 
recorded.  The structures within 6 kcal of the lowest energy structure (43 structures) are 
shown plotted as φ2 vs. ψ2 about the central Dibg residue (Figure 3.1).  Not surprisingly 
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most of the lowest energy structures for this tripeptide (blue circles) fell in two domains, 
the fully extended conformation, φ, ψ  = 180° and the gauche regime where φ2, ψ2 = ±30-
60°.  There were also several low energy conformations where one backbone dihedral 
angle was extended and the other one gauche; though these structures tended to be higher 
energy structures (yellow triangles, 4-6 kcal above the lowest energy structure).   
Interestingly, when the same peptide was set into a right-handed helical 
conformation (φ1/3 = -57°, ψ1/3 = -47) and subjected to simulated annealing, the resulting 
structures were all much higher in energy (>5 kcal) than the sheet-like conformations 
shown here.  
 
Figure 3.1 Left: Lowest energy conformations of Ac-Val-Dibg-Ala-NHMe plotted as φ2 
versus ψ2.  Right:  stick representation of tripeptide in fully extended conformation 
 
A representative space-filling model of one the φ2, ψ2 = 180° structures is shown 
in the bottom of Figure 3.2.  This is compared to the minimized starting structure with all 
backbone angles locked in a proteinogenic β-sheet conformation at the top of Figure 3.3.  
Note how the isobutyl chains of the minimized structure wrap around the backbone and 
also force the isopropyl group of the N-terminal Val to rotate to accommodate the 
"lower" isobutyl group of the Dibg residue. The lower alkyl group should lead to 
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additional hydrophobic interactions or electrostatic interactions if it was a charged group 
in sheet structures, which are not normally present in proteinogenic sequences.  The "C5" 
H-bond of the Dibg residue is clearly seen in the lower structure.  Additionally the 
backbone is somewhat kinked relative to the "flat" sheet represented above.  These 
modeling results suggest that ααAAs with larger side-chain groups can be 
accommodated into β-sheet structures.   
 
Figure 3.2 Above:  Ac-Val-Dibg-Ala-NHMe in β-sheet conformation.  Below: Same, in 
low energy conformation with φ2, ψ2 = 180° 
 
3.2.2 Synthesis of α,α−Diisobutylglycine (Dibg) 
α,α−Diisobutylglycine (Dibg) and α,α−dipropylglycine (Dpg) were traditionally 
synthesized from a ketone using the Bucherer-Bergs method via a hydantoin intermediate 
which then can be hydrolyzed to Dibg and Dpg.13  This method was optimal for Dpg 
synthesis; however major flaws were associated with this approach in reference to Dibg 
due to the high resistance of formation and hydrolysis of hydantoin because of the two 
bulky isobutyl groups. The yields in hydantoin formation and hydrolysis for the Dibg 
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synthesis are only 12% and 11% respectively compared to those of 64% and 67% 

















R = CH2CH3                                    64%                                          67% 
R = CH2CH(CH3)2               12%                                         11% 
Figure 3.3 Synthesis of Dpg and Dibg via Bucherer-Bergs reaction 
To overcome this problem, Dibg was synthesized via tetrakis-
(triphenylphosphine)palladium(0)-catalyzed allylation of ethyl α-nitroacetate using 2-
methylallyl acetate  in excellent overall yield by following a method developed in 
Hammer’s lab as illustrated in Figure 3.4.14 
The first step in the synthesis is to form two new carbon-carbon bonds by 
palladium-catalyzed diallylation of ethyl α-nitroacetate in dry THF with 2-methylallyl 
acetate in the presence of 2 equiv of DIEA, and 0.1 equiv of Pd(PPh3)4 . The highly 
acidic α-nitroacetate has been found to be a useful substrate for the formation of carbon-
carbon bond in a variety of reactions in which the acidic proton was replaced by carbon-
bond substituent. DIEA was used to remove two α-protons from nitroacetate to form α-
nitroacetate anion, which acts as nucleophile to attack the palladium π-allyl complex of 
Pd (II) to give excellent yields of the diallylated α-nitroacetate. Previously, the palladium 
catalyst was removed using PS-PPh3 resin. However, not all the palladium catalyst was 
scavenged using PS-PPh3 resin and as a result, purification of the crude compound was 
problematic. A revised method was developed in order to overcome this problem. Crude 





























Figure 3.4 Synthesis of Dibg via (Ph3P)4Pd catalyzed diallylation of ethyl nitroacetate 
 The next step involves the reduction of the nitro group and the side chain alkene 
to afford the amino ester in one step via hydrogenation over H2 at 50 psi for 20 hrs with 
Raney nickel in 87% yield  
The ester was hydrolyzed under strong basic conditionsb using 3M KOH. HCl 
was then added to the solution to precipitate the compound out as Dibg-HCl salt. The free 
Dibg was isolated in good yield by Dowex cation-exchange resin column with sulfonic 
acid functional group.  
The free amino acid 4 was then Nα protected with an Fmoc group to allow for 
solid phase peptide synthesis. The Nα-protection of the amino group was carried out 
using an in situ silylation procedure affording Fmoc-Dibg in excellent 91% yield.15 Two 
Equivalents of trimethylsilychloride (TMS-Cl) were added to form the intermediate O, N-
bis-trimethylsilyl-Dibg. The TMS group was introduced in order to temporarily protect 
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the carboxyl group, which eliminated the oligomerization side reactions, such as the 
formations of di- or tripeptides as shown in Figure 3.5 below. TMS group can be readily 
removed by mild hydrolysis. The product 5 was verified by 1H NMR and 13C NMR and 










Figure 3.5 O, N-bis-trimethylsilyl-Dibg 
3.2.3 Peptide Synthesis 
 Peptides listed in Table 3.1 were synthesized using Fmoc chemistry via solid-
phase peptide synthesis on a peptide amide linker-polyethylene glycol-polystyrene 
(Fmoc-PAL-PEG-PS) resin as a solid support. 









All coupling reactions except the acylation of the N-terminus of Dibg and 
acylation of the N-terminus of peptide Dibg3-NG peptide and peptide Leu3-NG were 
carried out in DMF using PyAOP and DIEA as the coupling reagents. Fmoc removal was 
accomplished by a deblocking solution of 2% piperidine, 2% DBU in DMF. A double 
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coupling was performed for valine due to the difficult coupling of this amino acid to the 


























Figure 3.6 Coupling of Dibg to the peptide sequence in Dibg3-GHP 
The couplings before the Dibg residue were performed on the Applied Biosystem 
Pioneer Peptide synthesizer. The remaining amino acid residues were incorporated into 
the sequence manually. Coupling of Dibg to the resin-bound peptide was carried out 
using PyAOP as the activator in the presence of DIEA at 50°C on a shaker overnight due 
to the difficult coupling of the amino acid to the peptide sequence as shown in Figure 3.6. 
A double coupling was performed for Dibg coupling due to moderate coupling yields 
determined by UV analysis of Fmoc deprotection at 301 nm.16  
Fmoc amino acid symmetrical anhydrides were found to be more efficient 
reagents for acylation N-terminus of highly hindered α,α-disubstituted amino acids, such 
as Dibg and Dbzg compared to the uronium salt HATU and phosphonium salt PyAOP.17 
Thus, amino acid symmetrical anhydrides were synthesized to acylate the N-terminus of 
Dibg. The symmetrical anhydride of Fmoc amino acids was prepared by treatment of 10 
equivalents of the corresponding Fmoc amino acid with 5 equivalents of DCC in CH2Cl2 
at room temperature for 2 hrs as shown in Figure 3.7. The resulting DCU precipitate was 
removed via filtration. Coupling of the symmetrical anhydride onto resin-bound peptide 
was carried out by adding preformed symmetrical anhydride to the resin-bound peptide in 
DCE-DMF (9:1) at 50 ˚C for 4 hrs while shaking.  A double coupling procedure was 
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performed due to moderate coupling yields determined by UV analysis of Fmoc 
deprotection.  
For the symmetrical anhydride coupling, the best coupling efficiency has been 
found to be an aprotic nonpolar solvent system of dichloroethane (DCE) and DMF (9:1). 
We propose that the enhanced reactivity of the symmetrical anhydride may result from 
the more effective amide bond formation via anchimeric assistance in aprotic nonpolar 
solvent. The formation of hydrogen bonding between the hydrogen of incoming amino 
acid and the oxygen of the symmetrical anhydride is more pronounced in the aprotic 
nonpolar solvent.  
The crude Dibg3-GHP was 83% pure by HPLC analysis. The HPLC 
chromatogram and MALDI-MS spectrum for peptide Dibg3-GHP are shown in Figure 3.8 





























































Figure 3.8 HPLC chromotogram of crude peptide Dibg3-GHP. Gradient: 90% A (H2O, 
0.1%TFA) and 10% B (CH3CN, 0.1% TFA) to 30% A and 70% B over 60 mins at a flow 
rate 1mL/min.  
 
 
Figure 3.9 MALDI-MS spectrum of the main peak on HPLC. For MS of Dibg3-GHP, 
[M+1]+ m/z calcd.1486.7 Obsd. 1486.2 
 
3.2.4  Conformational Analysis of Peptides Containing Dibg  
A well-defined peptide model is essential to elucidate peptide secondary structure 
propensities and systematically investigate the relationship between sequence, folded 
structure and stability of peptide conformations. Autonomously folding model systems 
for α-helix have been extensively studied and there are well-established principles for 
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designing synthetic peptides that adopt α-helical secondary structure. For example, α-
helices display length-dependent stabilization; α-helices become more stable as the 
length of the helix grow longer. This length–dependent effect on conformational stability 
results from the balance between entropic cost of helix initiation and enthalpic benefit of 
helix propagation because helix initiation is thermodynamically unfavorable but helix 
propagation is favorable.18 In contrast, model β-sheet peptides have only been developed 
until recently because of their tendency to aggregate and form discontinuous polypeptide 
segments. The first short peptide that folds into a monomeric β-hairpin in aqueous 
solution was reported by Blanco and coworkers in 1993.19 This β-hairpin peptide has a 
sequence of YQNPDGSQA which was designed based on residues 15-23 
(YQSWRYSQA) of a naturally occurring β-hairpin protein tendamistat. The four central 
residues in the tendamistat fragment were replaced by NPDG in order to maximize turn 
probability. More recently, several stable, non-aggregating, monomeric β-hairpins were 
synthesized and identified.20-22  The general design strategies for these β-hairpin peptides 
are the incorporation of type I′ or type II′ β-turn and favorable long range side chain-side 
chain interactions to promote and stabilize anti-parallel β-hairpin formation. 
β-Hairpins contain two-stranded antiparallel β-sheets linked by a β-turn and 
compose of the simplest model of β-sheet structures which therefore can provide 
fundamental insights into β-sheet stabilization. One particularly appealing β-hairpin 
model was developed by Gellman and co-workers; a 12-residue peptide, 
RYVEVDPGOKILQ that adopts a β-hairpin conformation in aqueous solution with a 
two-residue loop, D-Pro-Gly, which promotes formation of a “mirror image” β-turn (type 
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II' turn) as shown in Figure 3.10. This peptide is designated as GHP, the abbreviation of 















































Figure 3.10 GHP: known to have a predominantly β-hairpin conformation in aqueous 
solution 
 
GHP serves as an excellent model to study β-sheet structure as the β-hairpin 
conformation is highly populated and stable and exhibits low tendency to aggregate.24 
Because of these favorable properties of GHP, we have selected this model to probe the 
role of ααAAs as design elements in both the strand and turn portions of β-hairpin and 
study their effects on conformational stability. Incorporation of ααAAs into β-strand 
portion of β-hairpin structure is of interest for prevention of protein misfolding.  
In the peptide Dibg3-GHP, Dibg was incorporated into position 3 of GHP in place 











































GHP R=iPr   R′=H           Dibg3-GHP    R,R′=iBu         Dpg3-GHP R,R′=Pr              
Figure 3.11 Sequence of peptide GHP, Dibg3-GHP, and Dpg3-GHP 
 89
The conformational behavior of Dibg3-GHP and Dpg3-GHP was investigated by 
circular dichroism (CD) spectroscopy as shown in Figure 3.12. CD spectrum of Dibg3-
GHP is characteristic of a β-sheet conformation with a maximum at 203 nm and a 
minimum at 217 nm. Dibg3-GHP possesses stronger intensities at both maximum (203 
nm) and minimum points (217 nm) than GHP, suggesting that Dibg is readily 
accommodated into a β-hairpin structure. Peptide Dpg3-GHP, where Dpg was 
incorporated into position 3 replacing Val-3, gave a CD which was characterized by a 
stronger negative band at 190 nm and red-shifted band at 205 nm, suggesting that the 
Dpg residue reduced the amount of β-hairpin structure. This indicates that side chain 
branching of ααAA plays an important role in stabilization of the β-sheet portion of the 
hairpin. 
 
Figure 3.12 CD spectra of GHP, Dibg3-GHP and Dpg3-GHP in sodium acetate buffer. 
Condition: 100 µM peptide in 1 mM sodium acetate buffer, pH=3.8, 20˚C.a 




α-Proton chemical shifts are found to be highly sensitive to conformational 
changes. α-Protons exhibit a downfield shift with respect to random coil conformations 
when in a β-sheet structure and an upfield shift when in helical and turn conformations.25  
Chemical shift deviations of α-protons from random coil values for the residues in the 
sheet portion of GHP, Dibg3-GHP, and Dpg3-GHP and the chemical shift difference 
between the two diastereotopic hydrogens of glycine are summarized in Figure 3.13. All 
α-protons for Dibg3-GHP experience significant downfield shift (>0.10 ppm) relative to 
the random coil conformation with the exception of the terminal Arg-Gln pair, suggesting 
that Dibg3-GHP is largely folded. The Hα of Leu-11 in Dibg3-GHP displays a downfield 
shift, while this Hα  in both GHP and Dpg3-GHP display an upfield shift indicating that 
Dibg3-GHP is more structured in comparison with GHP and Dpg3-GHP. Wishart and 
coworkers have demonstrated that “chemical shift index” ∆δHα = δHα(observed) - δHα(random coil) 
(Equation 1) is an accurate technique to determine the types of secondary structures.26 A 
group of adjacent residues containing three or more ∆δHα >0.1 are considered to be β-
sheets. Wishart et al. also pointed out chemical shift indices of the residues at either N or 
C terminus are often opposite in magnitude to those of the corresponding secondary 
structure. This type of fraying at N- and C-termini is typically observed for the terminal 
residues in a β-hairpin, which is consistent with our observation for the terminal Arg-Gln 
pair. Both the pattern of the α-proton chemical shift deviations ∆δHα  and the chemical 
shift index data for Dibg3-GHP suggest that Dibg3-GHP adopts a β-hairpin conformation 
and is largely folded in sodium acetate buffer at pH 3.8. 
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The separation of the diastereotopic α-proton  resonances of glycine has been 
shown to correlate with the extent of folding in β-hairpins as illustrated in the following 
equation:27, 28 Fraction folded(%)=δGlyobserved /δGlyfully folded; where fraction folded equals 
mole fraction of hairpin folded, δGlyobserved is the chemical shift of the proton observed 
experimentally, and δGlyfully folded  is the chemical shift of the proton in the fully folded 
state, which usually is the cyclic form of the peptide.  The chemical shifts for 
diastereotopic α-protons of glycine are 3.75 ppm, 3.42 ppm respectively in GHP, 3.83 
ppm, 4.03 ppm in Dpg3-GHP and 3.70 ppm, 4.10 ppm in Dibg3-GHP. The largest 
difference in chemical shift of the diastereotopic α-protons was observed in Dibg3-GHP 
with 0.40 ppm and the least in Dpg3-GHP with 0.20 ppm. The difference in GHP is 0.22 
ppm indicating that Dibg3-GHP is well folded and Dpg3-GHP is less structured, which is 
in good agreement with the CD results. 




















Figure 3.13 Chemical Shift Index (∆δHα) for GHP, Dibg3-GHP, and Dpg3-GHP at 3.5 
mM in 100 mM aqueous sodium deuterioacetate buffer (H2O: D2O 9:1), pH 3.8 at 278 K. 
∆δHα values were calculated using Equation 1 utilizing the random coil values of  Dyson 
et al.29 Gly values are the difference between the two diastereotopic hydrogens. 
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β-Sheet structures possess natural right-handed twist; Thornton et al. discovered 
that two-residue loops should adopt type I' or II' β-turn conformations in order to promote 
the formation of a β-hairpin because these β-turns match the natural right-handed twist of 
the β-sheet and promote sheet interactions between adjacent stands of the β-sheet.30 
Therefore design a stable β-turn with proper handedness is critical in order to generate 
stable β-sheet conformations. In GHP, the two-residue loop DPro-Gly promotes β-hairpin 
folding via a “mirror image” type II' turn in aqueous solution. 
ααAAs were incorporated into the i+1 position of the GHP loop in order to 
access the ability of ααAAs such as Dibg, Dpg, and Aib to stabilize the β-turn of β-
hairpin peptides. In the peptide Dibg6-GHP, Dibg was incorporated into i+1 position of 
the GHP loop in place of DPro, while in Dpg6-GHP and Aib6-GHP, DPro was replaced by 
Dpg and Aib respectively. The sequences of Dibg6-GHP, Dpg6-GHP, and Aib6-GHP are 














































Dibg6-GHP R,R′=iBu         Dpg6-GHP R,R′=Pr        Aib6-GHP  R,R′=Me  
Figure 3.14 Sequence of peptide Dibg6-GHP, Dpg6-GHP, and Aib6-GHP   
The CD spectrum of Dibg6-GHP exhibits a maximum at 203 nm with an 
ellipticity at about -1000, while GHP displays a maximum at 201 nm with an ellipticity at 
about 4000. The significant decrease of the maximum of Dibg6-GHP with respect to the 
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GHP as shown in Figure 3.15, suggests that Dibg destabilizes the turn structure. It further 
proves the fact by our modeling studies that Dibg favors the extended structure, rather 
than the turn structures. Thus, we can conclude that Dibg disfavors type I' or II' β-turn 
conformation. CD spectrum of Dpg6-GHP shows similar intensity at both maximum and 
minimum points as Dibg6-GHP indicating that Dpg possesses the similar destabilizing 
effect on the β-turn as Dibg. CD spectrum of Aib6-GHP exhibits similar CD band that 
almost overlays with GHP suggesting that they adopt similar structures. Masterson et al. 
have shown that Aib-Gly induces a type I' β-turn in GHP and shows equivalent folding as 
GHP based on CD and NMR analysis. The stabilizing effect of Aib on the type I' β-turn 
may be due to Aib is a strong promoter for turn or helical structures. 
 
Figure 3.15 CD spectra of GHP, Aib6-GHP, Dibg6-GHP, and Dpg6-GHP. Condition: 
100µM peptide in 1mM sodium acetate buffer, pH=3.8, 20˚C. 
a The CD of Aib6-GHP and Dpg6-GHP were run by Marcus Etienne. 
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The NMR analysis of GHP peptide revealed there are numerous NOEs between 
the side chains of Tyr-2 and Lys-9, Tyr-2 and Leu-11, indicating that interstrand side 
chain-side chain interactions resulting from those residues are critical in the stability of 
the β-hairpin. Waters and coworkers have found that aromatic interactions stemmed from 
the Phe-Phe cross-strand pair also contribute to the β-hairpin stability.31 The peptide 
Leu3-NG was designed to probe whether non aromatic residue with high sheet propensity 
would exhibit the same stabilizing effects on an extended structure as the aromatic 
tyrosine. Russell et al. suggested that sheet propensities are more important than cross-
strand interactions in the stability of the hairpin structure.32 This peptide includes the 
proteinogenic LAsn-Gly two residue loop which has been shown to induce β-hairpin 
folding via a type I' turn in aqueous solution.(Figure 3.16) 19, 33-35 LAsn-Gly loop can 
avoid complications that arise in the determination of the peptide structure due to the 














































Leu3-NG   R=H                           Dibg3-NG     R= CH2CH(CH3)2 
Figure 3.16 Sequence of peptide Leu3-NG and Dibg3-NG      
 
Tyr-2 and Leu-11 are replaced with two Thr respectively. Threonine possesses 
high sheet propensity allows us to probe the contribution of sheet propensities compared 
to interstrand side chain-side chain interaction and aromatic and aliphatic interaction. Thr 
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also has another favorable property in that it is not very hydrophobic, in contrast to other 
β-sheet promoting residues, such as valine and isoleucine.36  Thus, it will not affect the 
solubility of this peptide in aqueous solution. Non-proteinogenic Orn-8 is replaced by 
Lys. Gellman et al. have shown that replacing Orn-8 by Lys has no effect on 
conformational stability of the β-hairpin.24 
The CD spectrum of Leu3-NG exhibits a minimum at 197 nm which is a signature 
band of random coil structure as shown in Figure 3.17. This suggests cross-strand 
interactions between Tyr-2 and Leu-11, between Tyr-2 and Lys-9 are essential for the 
stability of GHP. In Leu3-NG, side chain of Thr might be too short to engage in a 
favorable diagonal inter-strand interaction with Lys compared to Tyr-2, thus cause the 
loss of conformational stability of the β-hairpin.  


























Figure 3.17 CD spectra of Dibg3-NG and Leu3-NG. Condition: 100 µM peptide in 1mM 
sodium acetate buffer, pH=3.8, 20˚C. 
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The contributions of Dibg to β-sheet stability have been examined with the 
peptide Dibg3-NG. Dibg3-NG contains Dibg at position 3 in place of Leu to probe 
structural effects of ααAA on the β-sheet formation.  The CD spectrum of Dibg3-NG 
shows a significantly diminishing of minimum at 197 compared to Leu3-NG indicating 
Dibg is more structured than Leu3-NG as illustrated in Figure 3.18. This suggests that the  
side chains of Dibg are able to impose backbone constraints to the peptide and make this  
peptide more structured compared to the non-constrained analogue. 
3.2.5 Synthesis and Characterization of Novel Chiral α,α-Disubstituted Amino 
Acids 
 
    3.2.5.1     Enantioselective Synthesis of α,α-Disubstituted Amino Acids 
 First, Schiff base substrate 11 was prepared by a mild and efficient reaction of the 
corresponding amino ester hydrochloride salt 10 with 4-chlorobenzaldehyde 9 using 
Na2CO3 in H2O & DCM as shown in Figure 3.18.37 4-Chlorobenzaldehyde is the limiting 
reagent; therefore it was not always detected by NMR. When excess 4-
chlorobenzaldehyde determined by NMR, the excess 4-chlorobenzaldehyde was removed 
by washing with 30% sodium sulfite. The resulting carbon-nitrogen double bond in 
Schiff base has increased acidity of the α-proton, which allows the use of mild basic 
condition to remove the α-proton.  
The enantioselective phase-transfer catalytic alkylation was performed by 
treatment of corresponding amino acid Schiff base 11 with 1.2 equivalents of alkyl halide 
along with chiral quaternary ammonium bromide salt (1 mol %)(Figure 3.19) in 
anhydrous toluene followed by addition of 5 equivalents of solid CsOH·H2O at 0 °C. 
Reaction completion was verified via TLC and the resulting mixture was dissolved in 
water and extracted with DCM. Emulsion, caused by the fine solid particles of 
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CsOH·H2O resulting in difficult in purifying compound 12. Different solvent systems 
have been investigated, such as ether and water, ethyl acetate and water, and DCM and 
water.  The least amount of emulsion occurred in the solvent system of DCM and water; 
therefore the extraction was carried out using DCM and water. After the extraction, the 
DCM layer was concentrated under reduced pressure.  
In this reaction CsOH·H2O was used to remove the α-proton to form the enolate 
ion pair intermediate with the chiral ammonium cation under the phase-transfer catalytic 
condition. The carbon-nitrogen double bond stabilized the carbanion of the enolate which 
was then reacted with alkyl halide to form a new carbon-carbon bond and generate a new 
stereogenic center. The reason for high enantioselectivity and absolute configuration is 
because the tight ion pair of chiral ammonium cation and the enolate only the re-face of 
the enolate is accessible for the alkylation reaction.38 
The next step in the synthesis is to hydrolyze the imine under acidic condition 
using 0.5 M citric acid to provide the carboxyl protected chiral amino acid 13 in good 
yields with high to moderate enantiomeric excess as listed in Table 3.2. 
The chiral amino acids were also synthesized via phase-transfer catalytic Michael 
addition. The Michael addition was performed under the same reaction conditions as the 
phase-transfer catalytic alkylation of amino acid Schiff base. The Michael addition only 
afforded the corresponding amino esters with 21% ee and 29% ee respectively as shown 
in Table 3.3 which are much lower enantiomeric excess compared to amino esters 
derived from the alkylation reaction as outlined in Table 3.2. The high reactivity of the t-
butyl-3-bromopropionate possibly underwent a non-phase-transfer catalyst mediated 
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Michael reaction at the interface of the solid phase and solution phase phases, which may 
account for the substantial decrease in optical purity. 
Three main steps have been proposed in the solid liquid phase-transfer alkylation 
process as illustrated in Figure 3.20:39 1) Deprotonation of α-proton of  the Schiff base 
with CsOH·H2O to form the enolate anion, which occurs at the interface between the 
solid-liquid layers; 2) Extraction of the enolate that formed as a result of the first step into 
the bulk organic phase by ion-exchange with the cation of the chiral quaternary 
ammonium salt to form a lipophilic ion-pair; 3) Creation of the new chiral center in the 
product by alkylation of the ion-pair at the re-face of the enolate with concomitant 
regeneration of the catalyst.  
The corresponding racemic amino esters were synthesized via phase-transfer 
alkylation reaction in order to provide the references for enantiopurity analysis by 19F-
NMR.  Alkylation of Schiff base with alkyl halide using 0.2 equivalent of tetra-n-
butylammonium bromide (TBAB) as the phase-transfer catalyst, in the presence of 
nonnucleophilic base potassium carbonate in anhydrous acetonitrile (MeCN).40 The 
reaction mixture was refluxed for 1hr. Cleavage of the imine with 0.5 M citric acid in 
tetrahydrofuran (THF) afforded the racemic amino ester in good yields as illustrate in 
Figure 3.21. 
Fmoc-α-benzyl-leucine was synthesized from tert-butyl α-benzyl-leucinate to 
allow for solid phase peptide synthesis. First the t-butyl ester was removed by hydrolysis 
with HCl. The HCl salt was neutralized with DIEA to release the free amino acid. The 
free α-benzyl leucine was then Nα-protected using an in situ silylation procedure where 






































 Entry  R1 R2 PG 
13-1 PhCH2  Bn 
13-2 PhCH2  Bn 
13-3 i-Bu PhCH2 t-Bu
13-4 i-Bu  t-Bu
13-5 i-Bu  Bn 











Figure 3.19 (S,S)-3,4,5-Trifluorophenyl-NAS bromide 
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Table 3.2 Alkylation of Schiff base to form chiral Cα,α-dialkylated amino ester 
Entry R1 R2X PG % Chemical yield % eea Configuration
 
13-1 PhCH2 allyl bromide Bn 52 91 S 
 
13-2 PhCH2 1-bromopropane Bn 60 89 S 
 
13-3 i-Bu benzyl bromide t-Bu 66 78 R 
 
13-4 i-Bu allyl bromide t-Bu 70 ndb _ 
 
13-5 i-Bu allyl bromide Bn 68 nd _ 
 
aEnantiopurities of entries 13-1, 13-2 and 13-3 were determined by  19F-NMR analysis. 


















Table 3.3 Michael addition of Schiff base to form chiral amino esterb 
entry       R1                  R2                                   PG              %Chemical yield     % ee     
13-6           PhCH2          
OBut
O                Bn                     48                   21 
13-7           i-Bu            
OBut
O                  Bn                     66                   29 






















































































































1. DIEA, TMSCl, 








Figure 3.22 Preparation of Fmoc-α-benzyl-leucine 
Crystal structures for tert-butyl α-benzyl-leucinate and Fmoc-α-benzyl-leucine 
are presented in Figure 23a and Figure 23b respectively. The crystals were obtained from 
DCM, ethyl acetate and hexanes respectively. 
 
 
Figure 3.23a ORTEP diagram of tert-butyl leucinate p-chlorobenzaldehyde Schiff base 
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Figure 3.23b ORTEP diagram of Fmoc-α-benzyl-leucine dimer.  
3.2.5.2 Enantiopurity Analysis of Chiral Amino Esters 
The enantiopurities of amino esters in Table 3.2 and Table 3.3 were determined 
by quantitative 19F-NMR analysis of the two diastereomeric Mosher amides, which have 
b e e n  p r e p a r e d  f r o m  a n  o p t i c a l l y  p u r e  c o m p o u n d  R - ( - ) - α - m e t h o x y -
α−trifluoromethylphenylacetyl chloride (MTPACl) with amino ester  in the presence of 


































Entry  R1 R2 
16-1 PhCH2  
16-2 PhCH2  
16-3 i-Bu PhCH2 
16-4 PhCH2 OBut
O
16-5 i-Bu          OBut
O
Figure 3.24 Preparation of Mosher amide for 19F-NMR analysis 
The ααΑΑs possess sterically hindered amino functions because the alpha carbon 
is disubstituted with two bulky groups; therefore 0.1 equivalent of 4-
dimethylaminopyridine (DMAP) was used as a nucleophilic acylation catalyst to speed 
up this reaction as illustrated in Figure 3.25.42 DMAP reacts with acyl chloride to form an 
acylpyridinium ion first. The acylpyridinium ion reacts with the amine rapidly to form the 
amide bond and regeneration of DMAP. The inclusion of DMAP in acylations by acid 
anhydrides and acyl chlorides have been shown to increase acylation rates by up to four 



















Figure 3.25 DMAP catalyzed acylation reaction  
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19F NMR spectra of Mosher amides show two singlet signals for two 
diastereomeric Mosher amides R, R and R, S respectively. Integration of the two signals 
provides the enantiomeric excess of the two amino ester enantiomers. The peak areas for 
the two signals resulting from racemic amino esters are identical indicating that the 
enantiomeric excess for the racemic mixture is zero. The two diastereomers of Mosher 
amides formed from reacting the Mosher-chloride with the racemic amino ester have 
identical chemical shifts in reference to the two diastereomeric Mosher amides resulting 
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Figure 3.26 19F NMR spectra of diastereomers of Mosher amides 
a. 19F NMR spectrum of diastereomers of Mosher amides made from chiral benzyl α-
propyl-phenylalaninate. b. 19F NMR spectrum of diastereomers of Mosher amides 
made from racemic benzyl α-propyl-phenylalaninate. c.19F NMR spectrum of 
diastereomers of Mosher amides made from chiral benzyl α-allyl-phenylalaninate. d. 
19F NMR spectrum of diastereomers of Mosher amides made from racemic benzyl α-
allyl-phenylalaninate 
         a 
      b 
       c 
    d 
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Determination of enantiomeric excess based on fluorine resonance, is usually 
more reliable than proton resonances, because the fluorine signals are simple and located 
in an uncongested region. The fluorine NMR spectra taken at 235 MHz showed a 
chemical shift difference of 0.4-0.7 ppm between diastereotopic α-trifluoromethyl groups. 
Such differences permitted precise integrations of the fluorine signals. Comparable 
precision in measuring the signals from the diastereotopic proton was not always possible 
because of signal overlap.  
The enantioselectivity of tert-butyl α-benzyl-leucinate (entry 13-3 in Table 3.2) 
was also determined by HPLC analysis. The HPLC profile and 19F NMR spectrum for 
enantiomers of tert-butyl α-benzyl-leucinate are illustrated in Figure 3.27 and Figure 3.28 
respectively. HPLC analysis was carried out using a chiral column (DAICEL Chiralpak 
AD-H) and monitored at 254 nm with hexanes: 2-propanol as a solvent, The enantiomeric 
excess is 79% from HPLC analysis and the enantiomeric excess is 78% based on 19F 
NMR analysis.  Therefore, the two methods give the almost identical results. 












Figure 3.27 HPLC chromatogram of enantiomers of tert-butyl α-benzyl-leucinate. 
Conditions: hexanes:2-propanol(99:1), 25 °C 
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−67.5 −67.6 −67.7 −67.8 −67.9 −68.0 −68.1 −68.2 ppm 
−67.5 −67.6 −67.7 −67.8 −67.9 −68.0 −68.1 −68.2 ppm 
Figure 3.28a 19F NMR spectrum of Mosher amides made from chiral tert-butyl α-
benzyl-leucinate, Figure 3.28b 19F NMR spectrum of Mosher amides made from racemic 




3.3  Conclusions and Future Research Direction 
To summarize, Dibg was synthesized via palladium catalyzed allylation reaction 
with an excellent overall yield and incorporated into various positions of a model β-
hairpin peptide GHP in order to determine the effectiveness of the tetrasubstituted amino 
acids as design elements in both the strand and turn portions of β-hairpins. CD and NMR 
data of Dibg containing peptides showed Dibg residue can contribute to the stability of 
the strand portion of a β-hairpin peptide and destabilize the β-turn in the GHP. The sheet 
stabilizing effect of Dibg may be due to the strong propensity of Dibg to have a fully 
extended conformation(φ/ψ= 180°). The unordered structures in Dibg3-NG and Leu3-NG 
suggest that  the proteinogenic LAsn-Gly two residue loop, despite having a strong 
preference for  a type I' turn formation in aqueous solution, is incapable generating the β-
hairpin in the absence of the favorable interstrand side chain-side chain interaction and 
aromatic and aliphatic interaction.  
Several chiral amino esters were prepared with high enantioselectivity by 
alkylation of the corresponding Schiff bases under chiral phase-transfer condition. The 
enantiomeric excess of these chiral amino esters was efficiently determined by 19F-NMR 
analysis of the corresponding diastereomeric Mosher amides. The chiral ααAAs will be 
incorporated into the hydrogen bonding positions of the model β-hairpin peptide GHP to 
study their conformational effects on β-sheet peptides. 
3.4  Experimental  
• General Methods 
TLC was performed on Merck silica gel 60 F254 plates and visualized by 
ultraviolet light, exposure to iodine vapor or ninhydrin test. Flash column 
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chromatography was performed using silica gel 60 (230-400 mesh).  1H spectra were 
recorded on a 250 MHz spectrometer and 19F spectra were recorded on a 235 MHz 
spectrometer. 
• Representative Procedure for Synthesis of Fmoc-Dibg Amino Acid 
To the solution of ethyl nitroacetate 1 (2 g, 15 mmol) in dry THF (100 mL) 2-methylally 
acetate (3.42 g, 30 mmol) and Pd(PPh3)4 (1.73 g, 1.5 mmol) were added and after 20 
minutes DIEA (3.81 g, 30 mmol) was added and the reaction was stirred under argon for 
10 hrs at 50˚C. The resulting solution was filtered over celite and washed with THF twice. 
The filtrate was concentrated, dissolved in 40 mL of EtOAc and washed with 10% 
K2CO3. To the organic layer PS-PPh3 (1.3 mmol/g) Argonaut resin was added and shaken 
for 30 minutes. The resin was filtered off and the filtrate was purified via column 
chromatography (ethyl acetate-hexane 2:1) to provide ethyl 2,2-bis(2-methylallyl)-2-
nitroacetate 2, light yellow oil . Yield, 3.26g (90%). 1H NMR (250 MHz, CDCl3) δ 4.96-
4.95(m, 2H) 4.80(m, 2H), 4.28-4.20(q, 2H), 3.03-3.02(m, 4H), 1.71(m, 6H), 1.31-1.26(t, 
3H) 
To a solution of 2 (3.26 g, 13.5 mmol) in absolute ethanol (15 mL) glacial acetic acid (2 
mL) and a 50% (w/w) slurry of Raney nickel in water (2 g) were added. The solution was 
reduced via hydrogenation over H2 (50 psi) for 20 hrs. The resulting solution was filtered 
carefully over celite and washed with ethanol. (Note: Raney nickel is very pyrophoric 
when dry). The solvent was removed under reduced pressure and the crude was dissolved 
in diethyl ether (25 mL). After washing with saturated sodium carbonate and brine, the 
organic fraction was dried over anhydrous sodium sulfate and rotary evaporated to yield 
ethyl 2, 2-diisobutylglycine ester (3) 2.53 g  (87%). 1H NMR (250 MHz, CDCl3) δ 4.12-
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4.10 (q, 2H), 1.75-1.68 (m, 6H ),  1.49 (m, 2H ),  1.32-1.26 (t, 3H), 0.95-0.94 (m, 6H), 
0.93-0.81 (m, 6H). 
A suspension of 3 (2.53 g, 11.8 mmol) in 3M KOH (50 mL) and ethanol (35 mL) was 
refluxed under argon for 12 hrs. The resulting mixture was concentrated to 10 mL and 
acidified to pH 6.5 with 12 N HCl. The solvent was evaporated and the residue was 
redissolved in a minimum amount of water. The mixture was added to an activated 
Dowex 50*8-400 ion-exchange resin (50 g). Resin was activated by the following 
procedure: 1. wash resin with 2N HCl till acidic, then wash resin with distill water and 
methanol. After sample was loaded, eluted resin with methanol (250 mL), H2O (500 mL), 
and 2 N NH4OH (500 mL) respectively. The collected 2 N NH4OH fractions were 
evaporated under reduced prssure to give the free α,α−diisobutylglycine 4 as a white 
powder. Yield, 1.97 g (89%). 1H NMR (250 MHz, DMSO-d6) δ 7.3 (bs, 2H), 1.7-1.47 (m 
6H), 0.85-0.83 (m, 12H).  MALDI-MS of Dibg, [M+1]+ m/z calcd.188.2, Obsd. 188.2. 
Free Dibg (1.97g, 10.5mmol) was placed in a 2 neck round bottom flask fitted with a 
heating mantle and condenser. The solid was suspended in anhydrous CH2Cl2 (30 mL) 
and stirred vigorously. TMS-Cl (21 mmol, 2 eq) was added. The mixture was then 
refluxed for 6 hrs and allowed to cool in an ice bath. Diisopropylethylamine (3.2mL, 
1.7eq) and Fmoc-Cl (1.9g, 0.7eq) were added. The solution was stirred with cooling for 
20 min and warmed to room temperature overnight. The mixture was concentrated to 
remove CH2Cl2. The product was dissolved in ethyl acetate and the organic layer washed 
with 1N HCl twice. The organic layers were dried over anhydrous MgSO4 and 
concentrated under reduced pressure. The crude product was triturated in hexanes to 
afford a white solid Fmoc-Dibg 5. Yield, 3.91g (91%). 1H NMR (250 MHz, DMSO-d6)  
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δ  7.89−7.31 (m, 8H), 6.40 (s, 1H), 4.4 (d, 2H) , 4.2 (t, 1H), 2.01−1.99 (m, 2H), 
 1.62−1.44 (m, 4H),  0.79−0.75 (m, 12H). Elemental Analysis: Calcd for C25H31NO4: C, 
73.32; H, 7.63; N, 3.42. Found: C, 73.53; H, 7.49; N, 3.45. 
• Peptide Synthesis 
Peptides listed in Table 3.1 were synthesized using Fmoc chemistry via solid-
phase peptide synthesis on a peptide amide linker-polyethylene glycol-polystyrene 
(Fmoc-PAL-PEG-PS) resin as a solid support. The side-chain protected amino acid 
derivatives utilized were Fmoc-Arg(Pbf)-OH, Fmoc-Dibg-OH, Fmoc-Glu(OtBu)-OH, 
Fmoc-Val-OH, Fmoc-D-Pro-OH, Fmoc-Gly-OH, Fmoc-Orn(Boc)-OH, Fmoc-Ile-OH, 
Fmoc-Leu-OH, Fmoc-Gln(Trt)-OH, Fmoc-Lys(Boc)-OH, Fmoc-Orn(Boc)-OH, and 
Fmoc-Thr(tBu)-OH.  Unless indicated otherwise, molar equivalents are given over resin-
bound amine. 
All coupling reactions except the acylation of the N-terminus of Dibg and 
acylation of the N-terminus of Dibg3-NG and Leu3-NG were carried out in DMF using 
four equivalents of Fmoc-amino acids and activation with 4 equivalents PyAOP, and 8 
equivalents DIEA. A deblocking solution of 2% piperidine, 2% DBU in DMF was used 
for Fmoc removal. A double coupling was performed for valine due to the difficult 
coupling of this amino acid to the peptide sequence because of its sterically bulky side 
chain. The couplings before the Dibg residue were performed on the Biosystem Pioneer 
peptide synthesizer. The remaining amino acid residues were incorporated manually into 
the sequence. Dibg coupling was carried out using the PyAOP activator in the presence 
of DIEA at an elevated temperature of 50°C on a shaker for overnight due to the difficult 
coupling of the amino acid to the peptide sequence. A double coupling was performed for 
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Dibg coupling due to moderate coupling yields determined by UV analysis of Fmoc 
deprotection. 
Symmetrical anhydride of Fmoc amino acids was prepared by treatment of 10 
equivalents of corresponding Fmoc amino acid with 5 equivalents of DCC in CH2Cl2 at 
room temperature for 2 hrs. The resulting DCU precipitate was removed via filtration. 
Coupling of the symmetrical anhydride onto resin-bound peptide was carried out by 
adding preformed symmetrical anhydride to the resin-bound peptide in DCE-DMF (9:1) 
at 50 ˚C for 4 hrs while shaking.  A double coupling procedure was performed due to 
moderate coupling yields determined by UV analysis of Fmoc deprotection.  
After the symmetrical anhydride coupling, the resin-bound peptide was rinsed 
with DMF for 5 times. The deprotection solution, 10 mL 20% piperidine in DMF was 
added to the resin-bound peptide and shaken for 5 min, then the deprotection solution 
was filtered and  the resin-bound peptide was washed with DMF for 3 times. A second 
treatment with deprotection solution to resin-bound peptide occurred for 20 mins while 
shaken then filtered and rinsed. After the resin was washed with DMF for 5 times, 4 
equivalents of Fmoc-Arg(pbf)-OH, 8 equivalents of DIEA, 10 mL DMF were added to 
the resin and shaken for 2 hrs. The resin was then washed with DMF for 5 times and air 
dried for 10 min. The coupling efficiency was monitor by bromophenol blue test, 
ninhydrin test and Fmoc test described as below: 
• Bromophenol Blue Test Protocol43 
1. Add 1% bromophenol blue to acetonitril or N, N-dimethylacetamide to make 
bromophenol blue solution. 
2. Sample a few resin beads and wash several times with DCM. 
 115
3. Transfer the resin to a test tube and add 3 to 5 drops of bromophenol blue solution. 
4. The presence of resin-bound free amine is indicated by blue resin beads. Yellow 
stained   resin beads indicate the completion of the coupling reaction. 
• Ninhydrin Test Protocol44 
1. Add 5 % ninhydrin in ethanol, 80 % phenol in ethanol, 15 % water together to a vial to 
make ninhydrin solution. 
2. Sample a few resin beads and wash with ethanol 3 times in a syringe fitted with a frit 
and sit on an Erlenmeyer flask connected through a vacuum adaptor.  
3. Transfer to a test tube and add 3 drops of ninhydrin solution. 
4. Blue stained resin beads indicate the presence of resin-bound free amine. The 
α,α−disubstituted amino acid Dibg do not yield a positive reaction, thus give false 
negative results. 
• Fmoc Test Protocol 
1. Transfer small quantity of resin to a 10 mL syringe fitted with a frit and sit on an 
Erlenmeyer flask connected through a vacuum adaptor.  
2. Wash resin 10 times with DCM, apply vacuum for each wash to drain off the DCM. 
3. Dry resin for 1 hour under vacuo. 
4. Weigh out 4 to 8 mg of dry resin; return any unused resin to reaction flask. 
5. Treat the resin with 1 mL 20% piperidine in DMF solution for 30 mins. 
6. Remove the piperindine/DMF solution and add to a graduated cylinder. Wash resin   
with 1 mL of MeOH for 6 times; combine the 6 portions to the graduated cylinder. This 
is the sample solution for UV analysis. 
7. Prepare the reference solution of 1 mL piperindine in DMF in 6 mLs MeOH. 
 116
8. Place the reference solution into the UV cell and acquire UV spectrum form 240 nm to 
350 nm. This is the back ground spectrum. 
9. Acquire UV spectrum of sample solution in same wavelength range; correct for 
background. 
10. Calculate the substitution level, coupling and percent coupling using the equations 
below. 
       Substitution level = [(Absorbance@301 nm x 106) x 0.007] 
                                       [7800 x cell path length (cm) x weight of resin (mg)] 
Coupling efficiency = Substitution level per above/Substitution level of resin 
Percent coupling efficiency = Coupling x 100% 
Acetylation of N-terminus of Dibg3-NG and Leu3-NG was performed on the solid 
support by treatment with a solution of 0.2 M acetic anhydride and 0.28 M DIEA in DMF 
for 2 hrs. Once peptide assembly was completed, the peptide and side chain protecting 
groups were simultaneously cleaved off the resin with a cleavage cocktail: 88% 
trifluoroacetic acid, 5% phenol, 5% water and 2% triisopropylsilane (88:5:5:2 
TFA:phenol:water:TIPS) and precipitated out from cold ether for overnight.  
• Peptide Purification and Characterization 
Crude peptides were purified by reverse-phase high-performance liquid 
chromatography (HPLC) on a Waters Delta-Pak C18 column (15 µm, 300Å, 8 x 100 mm) 
with a gradient from 90% A (H2O, 0.1%TFA) and 10% B (CH3CN, 0.1% TFA) to 30% A 
and 70% B over 60 mins at a flow rate of 1mL/min. Semi preparative conditions were 
carried out using a Waters preparative Delta-Pak C18 column (15 µm, 300 Å, 25x100 mm)  
at a flow rate of 20mL/min. The homogeneity (> 99%) was confirmed by analytical 
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reverse-phase HPLC monitoring at the wavelength of 220 nm  with the scan wavelength 
from 200 to 400 nm  using a Vydac C18 column (5 µm, 4.6 x 250 mm) and identity of the 
peptides was determined by matrix-assisted laser desorption ionization-time of flight 
(MALDI-TOF) on a Bruker Proflex III instrument with XMASS software. 
Table 3.4 Analytical HPLC retention time and corresponding MALDI-MS results 
Peptide             Retention time(min)                          MALDI (M+H)+ m/z 
                                                                            Calculated                  Observed 
Dibg3-GHP             38.5                                       1486.7                        1486.2 
Dibg6-GHP             40.8                                       1488.7                        1488.6 
Dibg3-NG               24.9                                       1482.7                        1483.3 
Leu3-NG                 32.4                                       1427.7                        1427.9 
 
Representative Procedure for Preparation of Schiff Base 
1. Preparation of tert-butyl leucinate p-chlorobenzaldehyde Schiff base. 
Leucine hydrochloride tert-butyl ester (1 g, 4.47 mmol) and sodium carbonate (0.474 g, 
4.47 mmol) were dissolved in water (50 mL), CH2Cl2 (50 mL) and 4-chloro-
benzaldehyde (0.628 g, 4.47 mmol) was added. The mixture was stirred at 40 °C for 45 
mins. The reaction was then allowed to react at room temperature for 16 hrs. The 
resulting mixture was extracted with CH2Cl2 and water.  The organic layer was dried over 
MgSO4 and evaporated under reduced pressure to afford the crude imine as a colorless oil. 
(1.2 g, 86.8%). 1H NMR (250 MHz, CDCl3) δ 8.24 (s, 1H) 7.75-7.70 (d, 2H), 7.42-7.40 
(d, 2H), 3.99-3.94 (t, 1H), 1.83-1.77 (m, 2H) 1.63-1.52 (m, 1H), 1.49-1.45 (s, 9H), 0.97-
0.89 (dd, 6H) 
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2. Preparation of benzyl phenylalaninate p-chlorobenzaldehyde Schiff base. 
Phenylalanine hydrochloride benzyl ester (2 g, 6.85 mmol) and sodium carbonate (0.73 g, 
6.85 mmol)  were dissolved in water (50 mL), CH2Cl2 (80 mL) and 4-chloro-benzaldehye 
(0.994 g, 6.85 mmol) was added. The mixture was stirred at 40 °C for 45 mins. The 
reaction was then allowed to react at room temperature for 16 h. The mixture was then 
extracted with CH2Cl2 and water. The organic layer was dried over MgSO4 and 
evaporated under reduced pressure to afford the crude imine as a colorless oil. Yield,  
2.57 g (99.2%). 1H NMR (250 MHz, CDCl3) δ 7.87 (s, 1H), 7.76-7.60 (d, 2H), 7.38-7.15 
(m, 12H), 5.19 (s, 2H), 4.23-4.19 (dd, 1H), 3.36-3.34 (dd, 1H), 3.19-3.16 (dd, 1H). 
Representative procedure for catalytic enantioselective allylation of benzyl 
phenylalaninate p-chlorobenzaldehyde Schiff base under phase-transfer conditions 
to form benzyl α−allyl phenylalaninate. (entry 13-1)  
To a mixture of benzyl phenylalaninate p-chlorobenzaldehyde Schiff base (800 mg, 2.12 
mmol), chiral catalyst (19 mg, 0.0212 mmol) and allyl bromide (214 µl, 1.2 eq) in 
anhydrous toluene (10 mL), CsOH·H2O (1.78 g, 5 eq) was added at 0 °C, and the reaction 
mixture was stirred vigorously for 1.5 hrs. Water was added and extraction was 
performed with CH2Cl2. CH2Cl2 was evaporated and the residue was re-dissolved into 
THF (10 mL). 0.5 M citric acid (20 mL) was added and stirred at room temperature for 1 
h. The aqueous phase was separated and washed with ether.  The aqueous phase was then 
basified by the addition of solid NaHCO3 and extracted with CH2Cl2. The organic 
extracts were dried over Na2SO4 and concentrated.  Purification of the residual oil was 
carried out via column chromatography on silica gel (ethyl acetate-hexanes 1:2) to yield 
product. Yield, 325 mg (52.32%). 1H NMR (250 MHz, CDCl3) 7.37-7.09(m 10H), 5.8-
 119
5.6(m, 1H), 5.14 (m, 4H), 3.25-3.20 (d, 1H), 2.9-2.7 (m, 2H), 2.4 (m, 1H), 2.1-1.8(bs, 
2H). 
Representative procedure for catalytic enantioselective benzylation of tert-butyl 
leucinate p-chlorobenzaldehyde Schiff base under phase-transfer conditions to form 
tert-butyl α-benzyl leucinate. (entry13-3) 
To a mixture of  tert-butyl leucinate p-chlorobenzaldehyde Schiff base  (300 mg, 0.97 
mmol), chiral catalyst (8.9 mg, 0.0097 mmol) and benzyl bromide (138 µl, 1.164 mmol, 
1.2 eq) in anhydrous toluene (4 mL), CsOH·H2O (814.5 mg, 4.85 mmol) was added at 0 
°C, and the reaction mixture was stirred vigorously for 1.5 hrs.  Water was added and 
extraction was performed using CH2Cl2. The solution was concentrated and re-dissolved 
in THF (10 mL). 0.5 M citric acid (10 mL) was added and the mixture was stirred at 
room temperature for 1 h. The aqueous phase was separated and washed with ether. 
The aqueous phase was then basified by the addition of solid NaHCO3 and extracted with 
CH2Cl2.  The organic extracts were dried over Na2SO4 and concentrated. Purification of 
the residual oil was carried out via column chromatography on silica gel (ethyl acetate-
hexanes 2:1) to yield tert-butyl α-benzyl leucinate. Yield, 168.97 mg (63%).1H NMR 
(250 MHz, CDCl3) 7.27-7.24 (m, 5H), 3.16 (d, 1H), 3.11(d, 1H), 1.85-1.60 (m, 3H), 1.45 
(s, 9H), 1.00-0.91(dd, 6H). 
Benzyl α-propyl phenylalaninate (entry 13-2) 
1H NMR (250 MHz, CDCl3) 7.36-7.34(m, 5H), 7.22-7.20(m, 3H), 7.08-7.05(m, 2H), 
5.13(s, 2H), 3.19(d, 1H), 2.76(d, 1H), 1.97-1.85(ddd, 1H), 1.79(bs, 2H), 1.65-1.55(ddd, 
1H), 1.50-1.32(m. 1H), 1.18-1.04(m, 1H), 0.92-0.86(t, 3H). 
tert-Buty α-allyl leucinate (entry 13-4) 
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1H NMR (250 MHz, CDCl3) 5.73(m, 1H), 5.13(m, 2H), 2.55(dd, 1H), 2.16(dd, 1H), 
1.72(m, 3),1.47(s, 9H), 0.97-0.87(dd, 6H) 
Benzyl α-allyl leucinate(entry 13-5) 
1H NMR (250 MHz, CDCl3) 7.31(m, 5), 5.54(m, 1H), 5.07(m, 3H), 3.90(m, 1H), 2.53(dd, 
1H), 2.16(dd, 1H), 1.96(m, 1H), 1.85-1.53(m, 2H), 0.88-0.72(dd, 6H) 
Benzyl α-tert-butyl propionate phenylalaninate (Entry 13-6) 
1H NMR (250 MHz, CDCl3) 7.37-7.20(m, 10H), 5.14(s, 2H), 3.18(d, 1H), 2.81(d, 1H), 
2.41(m, 1H), 2.19(m. 1H), 2.01(m, 2H), 1.82,(bs, 2H), 1.43(s, 9H) 
If the compound is UV inactive, the reaction can be flollowed by ninhydrin test. 
First Spot the TLC with compound and then immerse TLC into the ninhydrin solution. 
The plates were then immediately heated by a heat gun, which completes the ninhydrin 
test where the primary amines appear as blue-purple spots on the TLC plates and the 
incompletion of the reaction is indicated by the yellow spot on the TLC plate.   
Procedure for preparation of α-benzyl leucine HCl salt 
To the tert-butyl α-benzyl leucinate, 50 ml of 6 N HCl was added. The reaction mixture 
was refluxed under argon for over night. The water layer was washed with ether, then the 
water was removed under reduced pressure, then redissolved in water and lyophilize to 
dryness.1H NMR (250 MHz, D2O) 7.30(m, 5H), 3.25(d, 1H), 3.01(d, 1H), 1.95(dd, 1H), 
1.69(m, 2H), 0.84(dd, 6H) 
Representative procedure for preparation of racemic amino ester 
To the mixture of benzyl phenylalaninate p-chlorobenzaldehyde Schiff base (500 mg, 
1.32 mmol), allyl bromide (243 mg, 2.01 mmol), 0.1 eq tetra-n-butylammonium bromide 
(42.5 mg, 0.132 mmol ) in MeCN, finely ground technical grade potassium carbonate 
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was added and refluxed with stirring for 1h. The mixture was then cooled and filtered. 0.5 
M citric acid (20 mL) was added and stirred at room temperature for 1h. The aqueous 
phase was separated and washed with ether.  The aqueous phase was then basified by the 
addition of solid NaHCO3 and extracted with CH2Cl2. The organic extracts were dried 
over Na2SO4 and concentrated. Purification of the residual oil was carried out via column 
chromatography on silica gel (ethyl acetate-hexane 1:2) to yield benzyl α−allyl 
phenylalaninate.1H NMR (250, CDCl3) 7.39-7.10 (m 10H), 5.8-5.6 (m, 1H) 5.15-5.11(m, 
4H), 3.24-3.18 (d, 1H), 2.81-2.77 (m, 2H), 2.4-2.2 (m, 1H) 1.63 (s, 2H). 
Representative procedure for preparation of Mosher amide in order to determine 
the enantioselectivity of the chiral amino esters 
To R-(-)-α-methoxy-α−trifluoromethylphenylacetyl chloride (MTPA Cl, 0.032 g, 0.127 
mmol), benzyl α−allyl phenylalaninate(0.025 g, 0.085 mmol), 4-dimethylaminopyridine 
(0.001 g, 0.0085 mmol) and DIPEA (14.7 µL, 0.085 mmol) were added and allowed to 
react overnight at room temperature. The crude product was extracted using 1 N HCl and 
CH2Cl2. The organic layer was washed with 4 N NaOH, dried over anhydrous MgSO4, 
and evaporated under reduced pressure.19F NMR (235 MHz, CDCl3) -68.07(s), -68.52(s) 
Entry 16-2 19F NMR (235 MHz, CDCl3) -68.08(s), -68.75(s)  
Entry 16-319F NMR (235 MHz, CDCl3)   -67.67(s),  -68.12(s) 
Entry 16-419F NMR (235 MHz, CDCl3)  -68.10(s),   -68.74(s) 
Entry 16-519F NMR (235 MHz, CDCl3)  -68.75(s),  -69.02(s) 
Chiral HPLC analysis of tert-butyl α-benzyl-leucinate was carried out using a chiral 
column (DAICEL Chiralpak AD-H) with hexanes:2-propanol = 99:1.0, flow rate= 0.5 
ml/min,  25 °C, λ =254 nm, retention time: 16.13 min and 17.16 min respectively. 
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NMR SPECTRA OF COMPOUNDS AND PEPTIDES 
 

















1H NMR in CDCl3 
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1H NMR in DMSO-d6 
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1H NMR in CDCl3 
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400 MHz 1H NMR of 10 mM EK-Dpg-A in 30 mM phosphate buffer (H2O: D2O 9:1), 



















400 MHz 1H NMR of 10 mM EK-Dpg-Y in 30 mM phosphate buffer (H2O: D2O 9:1), 





400 MHz 1H NMR of 10 mM KE-Dpg-Y in 30 mM phosphate buffer (H2O: D2O 9:1), 






400 MHz 1H NMR of 10 mM EK-Dpg-V in 30 mM phosphate buffer (H2O: D2O 9:1), 
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400 MHz 1H NMR of 10 mM EK-Aib-Y in 30 mM phosphate buffer (H2O: D2O 9:1),  







Portion of 1H-13C HSQC spectrum of EK-Dpg-Y in phosphate buffer (H2O: D2O 9:1), pH 
























TOCSY spectrum of 10 mM EK-Dpg-Y in 30 mM phosphate buffer (H2O: D2O 9:1), pH 





ROESY spectrum of 10 mM EK-Dpg-Y in 30 mM phosphate buffer (H2O: D2O 9:1), pH 
























13C NMR spectrum of 10 mM EK-Dpg-Y in 30 mM phosphate buffer (H2O: D2O 9:1), 




























Portion of 1H-13C HMBC spectrum of 10 mM EK-Dpg-Y in phosphate buffer (H2O: D2O 

























1H-13C HMBC spectrum of 10 mM EK-Dpg-Y in phosphate buffer (H2O: D2O 9:1), pH 






Portion of 1H-13C HSQC-TOCSY spectrum of 10 mM EK-Dpg-Y in phosphate buffer 














































400 MHz TOCSY spectrum of 10 mM KE-Dpg-Y in 30 mM phosphate buffer (H2O: 
D2O 9:1), pH 7.0 at 278 K. A spin-lock mixing time of 144 ms was used. 
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400 MHz ROESY spectrum of 10 mM KE-Dpg-Y in 30 mM phosphate buffer (H2O: 



















400 MHz TOCSY spectrum of 10 mM EK-Aib-Y in 30 mM phosphate buffer (H2O: D2O 






















400 MHz ROESY spectrum of 10 mM EK-Aib-Y in 30 mM phosphate buffer (H2O: D2O 



























400 MHz TOCSY spectrum of 10 mM EK-Dpg-A in 30 mM phosphate buffer (H2O: 

























400 MHz ROESY spectrum of 10 mM EK-Dpg-A in 30 mM phosphate buffer (H2O: 



























400 MHz TOCSY spectrum of 10 mM EK-Dpg-V in 30 mM phosphate buffer (H2O: 


























400 MHz ROESY spectrum of 10 mM EK-Dpg-V in 30 mM phosphate buffer (H2O: 





700 MHz 1H NMR spectrum of 3.5 mM Dibg3-GHP in 100 mM aqueous sodium 








700 MHz ROESY spectrum of 3.5 mM Dibg3-GHP in 100 mM aqueous sodium 
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